<SEC-DOCUMENT>0001213900-23-037340.txt : 20230508
<SEC-HEADER>0001213900-23-037340.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508161134
ACCESSION NUMBER:		0001213900-23-037340
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20230504
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACTELIS NETWORKS INC
		CENTRAL INDEX KEY:			0001141284
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMUNICATIONS EQUIPMENT, NEC [3669]
		IRS NUMBER:				522160309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41375
		FILM NUMBER:		23897853

	BUSINESS ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		510-545-1040

	MAIL ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea178132-8k_actelis.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ASNS="http://actelis.com/20230504">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_ASNS_actelis.com_20230504 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230504_20230504 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001141284 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:EntityCentralIndexKey">0001141284</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="asns-20230504.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-04to2023-05-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001141284</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-04</xbrli:startDate>
        <xbrli:endDate>2023-05-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_907_edei--DocumentType_c20230504__20230504_zSEY4fd4qBWh"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of report (Date of earliest event reported):
<b><span style="text-decoration: underline"><span id="xdx_90C_edei--DocumentPeriodEndDate_c20230504__20230504_ztFTlxpEtrz5"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 4, 2023</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90A_edei--EntityRegistrantName_c20230504__20230504_zskRF0ac5hfg"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:EntityRegistrantName">Actelis Networks, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20230504__20230504_zslB76LnAbRd"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityFileNumber_c20230504__20230504_ztskiuFL0Dj3"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:EntityFileNumber">001-41375</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20230504__20230504_zjnG5N15dxGa"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:EntityTaxIdentificationNumber">52-2160309</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification Number)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20230504__20230504_zB0HoXpyy0X4"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:EntityAddressAddressLine1">4039 Clipper Court,</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressCityOrTown_c20230504__20230504_zMRLJ07WmeF9"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:EntityAddressCityOrTown">Fremont,</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressStateOrProvince_c20230504__20230504_zsJ6yKDNRu7"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_906_edei--EntityAddressPostalZipCode_c20230504__20230504_zNBZ2fWHQoa3"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:EntityAddressPostalZipCode">94538</ix:nonNumeric></span><br />
</span></b>(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">(<span id="xdx_902_edei--CityAreaCode_c20230504__20230504_z5KZMwbQXwC6"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:CityAreaCode">510</ix:nonNumeric></span>) <span id="xdx_90B_edei--LocalPhoneNumber_c20230504__20230504_z6CTa3JF3Whb"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:LocalPhoneNumber">545-1045</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instructions A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--WrittenCommunications_c20230504__20230504_z17SwAZkg2ma"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20230504__20230504_zhB6tRVWdM2f"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20230504__20230504_zZPQGQEzXK25"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20230504__20230504_zJzEtmTTUT6f"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20230504__20230504_zNAQvqFUUyF6"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:Security12bTitle">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20230504__20230504_zfLZ1uXBImfe"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" name="dei:TradingSymbol">ASNS</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SecurityExchangeName_c20230504__20230504_zvue0DFfRXIb"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span id="xdx_904_edei--EntityEmergingGrowthCompany_c20230504__20230504_z8GhTY8x57R2"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90B_edei--EntityExTransitionPeriod_c20230504__20230504_zwOrXiLl5z1d"><ix:nonNumeric contextRef="From2023-05-04to2023-05-04" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01. Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 4, 2023, Actelis Networks,
Inc. (the &#8220;Company&#8221;), a Delaware corporation, entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;)
with an accredited investor (the &#8220;Investor&#8221;), <span style="background-color: white">pursuant to which the Company agreed to
issue and sell to the Investor in a private placement (the &#8220;Offering&#8221;) (i) 190,000 shares (the &#8220;Shares&#8221;) of common
stock of the Company, $0.0001 par value (the &#8220;Common Stock&#8221;), (ii) 754,670 pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;)
to purchase up to 754,670 shares of Common Stock and (iii) warrants to purchase up to 944,670 shares of Common Stock (&#8220;Common Warrants&#8221;
and collectively with the Shares and the Common Warrants, the &#8220;Securities&#8221;) for a purchase price of $3.705 per share of Common
Stock and related Common Warrant or $3.7049 per Pre-Funded Warrant and related Common Warrant, for a total aggregate gross proceeds of
approximately $3.5 million. The Offering closed on May 8, 2023. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Common Warrants have an
exercise price of $3.58 per share, are exercisable immediately upon issuance and expire five and one-half years following the issuance.
The Pre-Funded Warrants were sold in lieu of shares of Common Stock, are exercisable immediately upon issuance, have an exercise price
of $0.0001 per share and expire when exercised in full. Under the terms of the Warrants and Pre-Funded Warrants, the Investor may not
exercise the warrants to the extent such exercise would cause the Investor, together with its affiliates and attribution parties, to beneficially
own a number of shares of common stock which would exceed 4.99% (or, at such Investor&#8217;s option upon issuance, 9.99%), of the Company&#8217;s
then outstanding Common Stock following such exercise, excluding for purposes of such determination shares of Common Stock issuable upon
exercise of such warrants which have not been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
representations, warranties, indemnification and other provisions customary for transactions of this nature. The Purchase Agreement also
provides that, subject to certain exceptions, until 60 days after the effective date of the registration statement to be filed in connection
with Offering, neither the Company nor any of its subsidiaries will issue, enter into any agreement to issue or announce the issuance
or proposed issuance of any shares of Common Stock or Common Stock equivalents or file a registration statement other than one in connection
with the Offering. The Purchase Agreement also provides that, subject to certain exceptions, for a period of one year following the effective
date of the registration statement to be filed in connection with Offering, the Company will be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its subsidiaries of Common Stock or Common Stock equivalents (or a combination
of units thereof) involving a variable rate transaction, which generally includes any transaction in which the Company (i) issues or sells
any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares
of common stock either (A) at a conversion price or exchange rate that is based upon and/or varies with the trading prices of or quotations
for the shares of common stock at any time after the initial issuance of such securities, or (B) with a conversion, exercise or exchange
price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence
of specified or contingent events directly or indirectly related to the business of the Company or the market for the common stock or
(ii) enters into any agreement, whereby the Company may issue securities at a future determined price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the Offering, the
Company entered into a Registration Rights Agreement, dated May 4, 2023, with the Investor, pursuant to which the Company agreed to register
the resale of the shares of Common Stock sold in the Offering and the shares of Common Stock issuable upon exercise of the Common Warrants
and the Pre-Funded Warrants. The Company will use its commercially reasonable best efforts to file the registration statement by May 24,
2023 and cause the registration statement to be declared effective within 45 days after May 4, 2023 (or 75 days in the event the registration
statement is reviewed in &#8220;full&#8221;). If the Company fails to meet the specified filing deadlines or keep the registration statement
effective, subject to certain permitted exceptions, the terms of the Registration Rights Agreement provide that the Company will be required
to pay certain liquidated damages to the Investor. The Company also agreed, among other things, to indemnify the Investor under the registration
statement from certain liabilities and to pay all fees and expenses incident to the Company&#8217;s performance of or compliance with
the Registration Rights Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Offering of the Securities,
including any shares of Common Stock issuable thereunder, was not registered under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;) and the Securities were offered and sold pursuant to the exemption provided in Section 4(a)(2) under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">H.C. Wainwright &amp;
Co., LLC acted as the exclusive placement agent for the issuance and sale of the Securities. The Company has agreed to pay up to an
aggregate cash fee equal to 7.0% of the gross proceeds received by the Company from the Offering. The Company also agreed to pay
Wainwright $65,000 for non-accountable expenses and a management fee equal to 1.0% of the gross proceeds raised in the Offering. The
Company also agreed to issue to Wainwright, or its designees, unregistered warrants to purchase up to 7.0% of the aggregate number
of the Shares and Pre-Funded Warrants sold to the Investor (or warrants to purchase up to 66,127 shares of Common Stock) at an
exercise price per share of $4.6313 and a term of five and one-half years (the &#8220;Placement Agent Warrant&#8221;). The Placement Agent Warrant and the shares of Common
Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided by Section 4(a)(2) of
the Securities Act as transactions not involving a public offering and in reliance on similar exemptions under applicable state
laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing
descriptions of the Common Warrants, the Pre-Funded Warrants, Placement Agent Warrant, the Purchase Agreement, and the Registration
Rights Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the agreements,
forms of which are attached as Exhibits 4.1, 4.2, 4.3, 10.1 and 10.2, hereto, respectively, and incorporated herein by
reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.02. Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The matters described in Item
1.01 of this Current Report on Form 8-K are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item&#160;<span style="background-color: white">7.01</span>
Regulation FD Disclosures.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 4, 2023, the Company
issued a press release regarding the pricing of the Offering. A copy of the press release is attached Exhibit 99.1 and it incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 8, 2023, the Company
completed the Offering and issued a press release regarding the completion of the Offering. A copy of the press release is attached as
Exhibit 99.2 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The following exhibits are filed herewith
or incorporated herein by reference:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%"><span style="font-size: 10pt"><b>&#160;Description.</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea178132ex4-1_actelis.htm">Form of Common Warrant.</a> </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea178132ex4-2_actelis.htm">Form of Pre-Funded Warrant.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>4.3</td>
    <td>&#160;</td>
    <td><a href="ea178132ex4-3_actelis.htm">Form of Placement Agent Warrant</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea178132ex10-1_actelis.htm">Form of Securities Purchase Agreement.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea178132ex10-2_actelis.htm">Form of Registration Rights Agreement.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea178132ex99-1_actelis.htm">Press Release issued May 4, 2023.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">99.2</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea178132ex99-2_actelis.htm">Press Release issued May 8, 2023.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACTELIS NETWORKS, INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: May 8, 2023</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%">/s/ Tuvia Barlev</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160; </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuvia Barlev </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">3</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PbSbCLI7HTrEKTJEvC0uk+LWjLT+7JF8S7sNMQSScM6XI0QoMtroGhkuqyKHEzZtrRxCgRUymit6R7rdJeBngTdtHSvjhvMHpuQZ9Mx8Ei2UFwbrU1ssE5DzqVxM45lfEhnDci+CXk/JVLpE47SqQZkSjkwta3SKu/HDSb3JUNMNUWdkq8kkEE3kKH8gllEMB3qqF/HdQp6nIgiHCkTG9Gj7mId11MC6xsZn2RH9d/AFEulJPw== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea178132ex4-1_actelis.htm
<DESCRIPTION>FORM OF COMMON WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Actelis
Networks, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: 944,670</FONT></TD>
    <TD STYLE="padding-left: 0in; text-align: left; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: May 8, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: May 8, 2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and
subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the
&ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on November 8, 2028 (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Actelis Networks, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 944,670 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 4, 2023, among the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $3.58, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(A) =</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(B) =</TD><TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white"><U>&ldquo;Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">&ldquo;<U>VWAP</U>&rdquo;
</FONT>means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company<FONT STYLE="background-color: white">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&nbsp;The
Company agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price
to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the
Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price
(other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason to
deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to
the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on
the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day
on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such
Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in
the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the
voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity
of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this
Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors,
the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the
same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders
of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock
or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration
in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not
offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common
stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.
&ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from
the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing
purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the
date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility
equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility or (3) the 365 day volatility, each of clauses (1)-(3) as
obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following
the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation
shall be the highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable
contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading
Day of the Holder&rsquo;s request pursuant to this Section 3(e) and (D) a remaining option time equal to the time between the date of
the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.
The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The
Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in
accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the
Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity
or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other
Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had
been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section
3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or
(ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Actelis Networks, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 31%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: <B>Actelis
Networks, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&nbsp;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&nbsp;Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">&#9744; if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4)&nbsp;<U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:&nbsp;______________________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:&nbsp;</FONT>_______________________________</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea178132ex4-2_actelis.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Actelis
Networks, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 70%">Warrant Shares: 754,670</TD>
  <TD STYLE="text-align: left; width: 30%">Issue Date: May 8, 2023</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">Initial Exercise Date: May 8, 2023</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, (the &ldquo;<U>Holder</U>&rdquo;) is entitled,
upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set
forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from Actelis Networks, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 754,670 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 4, 2023, among the Company and Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(A) =</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading
Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof
on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported
by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section
2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day
and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading
hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white"><U>&ldquo;Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">&ldquo;<U>VWAP</U>&rdquo;
</FONT>means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company<FONT STYLE="background-color: white">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&nbsp;&nbsp;The
Company agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price
to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the
Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price
(other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason to
deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to
the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on
the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day
on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such
Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in
the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the
voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity
of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this
Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other
Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably
satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at
the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value
of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares
of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the
consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence
of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that
from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other
Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor Entity or Successor
Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise
every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations
of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor
Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall
be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares
of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Actelis Networks,
  Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: <B>Actelis
Networks, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"> &#9744; if
permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ______________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: __________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ______________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:&nbsp;______________________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT>&nbsp;_______________________________</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ea178132ex4-3_actelis.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Actelis
Networks, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%">Warrant Shares: 66,127</TD>
    <TD STYLE="text-align: left; width: 30%">Issue Date: May 8, 2023</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD STYLE="text-align: left">Initial Exercise Date: May 8, 2023</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PLACEMENT AGENT COMMON
STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, H.C. Wainwright &amp; Co., LLC or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m.
(New York City time) on November 8, 2028 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase
from Actelis Networks, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 66,127 shares (as subject to adjustment
hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase
Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 4, 2023, among the Company and the purchasers signatory
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy
submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of
Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the
aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the
applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the
Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation as soon as reasonably practicable following the date on which the final Notice of Exercise is delivered to
the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)
Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $4.6313, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a
number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(A) =</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.4in; text-align: left">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white"><U>&ldquo;Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">&ldquo;<U>VWAP</U>&rdquo;
</FONT>means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company<FONT STYLE="background-color: white">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&nbsp;&nbsp;The
Company agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a
participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or
manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of
a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1)
Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the
Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share
Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason to deliver to the Holder the Warrant
Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as
liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common
Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading
Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are
delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with
respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of
Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is
required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise
purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the
amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of
Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was
required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise
to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and
equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded)
or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its
exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of
$11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise
to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon
exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay
all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or
another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any
other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons,
&ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below).&nbsp; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its
Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable
upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the
Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp;
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange
Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the
limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the
Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the
Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of
the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number
of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the
Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public
announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of
shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of
outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to
correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or
sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if
the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any
limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on
which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of
which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would
result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such
Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such
extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right
thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are
permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such
other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the
common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or
of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If
holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the
Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with,
or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the
applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the
Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such
Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s control,
including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any
Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised
portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the
Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders
of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not offered or paid any
consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the
Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.
&ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained
from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the
time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date,
(B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility or (3) the 365 day
volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction,
(C) the underlying price per share used in such calculation shall be the highest VWAP during the period beginning on the Trading Day
immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the
applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section
3(e) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated
Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made
by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the
Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume
in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this
Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term
&ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer
instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or
Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the
other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and
severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the
provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the
issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the
sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall
promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions
of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the
Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall
issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be
cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the
Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of
Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of
this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current
public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the
Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for
distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state
securities law, except pursuant to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in
accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this
Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be
sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of
appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its
rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
to the address for the Holder that appears in the Company&rsquo;s Warrant Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or
by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to
specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the
defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to
the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of
Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand,
and the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be
ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>Actelis Networks, Inc.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">By:</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"></TD>
  <TD STYLE="width: 5%">Name:&nbsp;</TD>
  <TD STYLE="width: 31%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD></TD>
  <TD>Title:&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: <B>Actelis
Networks, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"> &#9744; in
lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"> &#9744; if
permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp;</TD>
    <TD>(Please Print) </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Signature:&nbsp;______________________________</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Address:&nbsp;_______________________________</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ea178132ex10-1_actelis.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B>SECURITIES PURCHASE
AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 4, 2023, between Actelis Networks, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase
from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.1   <U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations
at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York are generally open for use by customers on such day</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the common stock purchase warrant delivered to the Purchasers at the Closing in accordance with
Section 2.2(a) hereof, which Common Warrants shall be exercisable immediately upon issuance and have a term of exercise equal to five
and one-half (5.5) years, substantially in the form of <U>Exhibit A-2</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Pearl Cohen Zedek Latzer Baratz LLP, with offices located at 131 Dartmouth Street, Boston, Massachusetts 02116.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement registering for resale all Shares and Warrant
Shares has been declared effective by the Commission, (b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or
may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information required
under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date provided
that a holder of Shares or Warrant Shares is not an Affiliate of the Company, or (d) all of the Shares and Warrant Shares may be sold
pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions and
Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders of
the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, with offices at 1 State Street, New York, New York 10004.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the escrow agreement entered into, by and among the Company, the Escrow Agent and the Placement Agent pursuant
to which the Purchasers shall deposit Subscription Amounts with the Escrow Agent to be applied to the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) warrants
to the Placement Agent in connection with the transactions pursuant to this Agreement and any securities upon exercise of warrants to
the Placement Agent, securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided
that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the
exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or
to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority
of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined
in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the prohibition period in Section 4.11(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders
of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with
the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not
include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary
business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $3.705 (less $0.0001 for each Pre-Funded Warrant), subject to adjustment for reverse and forward stock
splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement
and prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means H.C. Wainwright &amp; Co., LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and will expire when exercised in full, substantially
in the form of <U>Exhibit A-1</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Shares and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in
United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded
Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Registration Rights Agreement, the Escrow Agreement, all exhibits and schedules
thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, NY 11598, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE II.</B><BR>
<B>PURCHASE AND SALE</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.1   <U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally
and not jointly, agree to purchase, up to an aggregate of $[________ of Shares and Warrants. Notwithstanding anything herein to the contrary,
to the extent that a Purchaser determines, in its sole discretion, that such Purchaser&rsquo;s Subscription Amount (together with such
Purchaser&rsquo;s Affiliates and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates)
would cause such Purchaser&rsquo;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership Limitation, or
as such Purchaser may otherwise choose, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares as determined pursuant
to Section 2.2(a). The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the election of the Purchaser at Closing,
9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the
Closing Date. In each case, the election to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser shall
deliver to the Escrow Agent, via wire transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set
forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Shares,
Pre-Funded Warrants and Common Warrants, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the
other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections
2.2 and 2.3, the Closing shall occur remotely by electronic transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.2   <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   a
legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers, in form and substance reasonably acceptable to the
Placement Agent and Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)   a
copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered
in the name of such Purchaser, or, at the election of such Purchaser, evidence of the issuance of such Purchaser&rsquo;s Shares hereunder
as held in DRS book-entry form by the Transfer Agent and registered in the name of such Purchaser, which evidence shall be reasonably
satisfactory to such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)   a
Common Warrants registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of the sum
of such Purchaser&rsquo;s Shares and Pre-Funded Warrant Shares, with an exercise price equal to $3.58, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)   if
applicable, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to
the difference between (A) such Purchaser&rsquo;s Subscription Amount divided by the Per Pre-Funded Warrant Purchase Price and (B) the
number of Shares otherwise issuable to such Purchaser that would cause such Purchaser&rsquo;s Beneficial Ownership to be more than the
Beneficial Ownership Limitation with an exercise price equal to $0.0001 per share of Common Stock, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)   the
Company shall have provided each Purchaser with the Escrow Agent&rsquo;s wire instructions; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)   the
Registration Rights Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company or the Escrow Agent, as applicable,
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   this
Agreement duly executed by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   to
the Escrow Agent, such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in writing by the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)   the
Registration Rights Agreement duly executed by such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.3   <U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) when
made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein
in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)   the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate in all respects or, to the extent representations or warranties are qualified
by materiality, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)   the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)   there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)   from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.1   <U>Representations
and Warranties of the Company</U>. Except as set forth in the SEC Reports, the Company hereby makes the following representations and
warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in
the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing (if applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization, with
the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither
the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and
is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)   <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property
or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in
a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not
have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)   <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) the filing with the Commission pursuant to the Registration Rights Agreement, (iii) the notice
and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Shares and
Warrant Shares for trading thereon in the time and manner required thereby, and (iv) the filing of Form D with the Commission and such
filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)   <U>Issuance
of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than
restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the terms of the
Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other
than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)   <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth in the SEC Reports<U>,</U> including the number of shares of Common
Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. The Company has not issued any capital stock
since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under
the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock
purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently
filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any
similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale
of the Securities and as set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls
or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable
for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or
contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional
shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not
obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers).
Except as set forth in the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary with any provision
that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company
or any Subsidiary. Except as set forth in the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any
stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance
with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others
is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements
with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among
any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)   <U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
(2) years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material
respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer
subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)   <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in
a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and
accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected
in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not
altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to
its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company
has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity incentive plans.
The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance
of the Securities contemplated by this Agreement or as set forth in SEC Reports, no event, liability, fact, circumstance, occurrence or
development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their
respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the
Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at
least (one) 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)   <U>Litigation</U>.
Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth in SEC Reports, (i) adversely affects or challenges the
legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)   <U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)   <U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)  <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)   <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)   <U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal,
state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither
delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by
them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)   <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). Except as set forth
in the SEC Reports, none of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the
Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within
two (2) years from the date of this Agreement, except where such action would not be reasonably be expected to have a Material Adverse
Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within
the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of
the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)   <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)   <U>Transactions
with Affiliates and Employees</U>. Except as set forth in the SEC Reports,, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with
the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing
for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee
or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits,
including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)   <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002, as amended, that are effective as of the date hereof and as of the Closing Date, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as
of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially
affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)   <U>Certain
Fees</U>. Except for compensation payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are
or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)   <U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.
The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)   <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)   <U>Registration
Rights</U>. Other than each of the Purchasers and as set forth in the SEC Reports, no Person has any right to cause the Company or any
Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)   <U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future
continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic
transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the
fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)   <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)   <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or
on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa) <U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under
the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the
Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb) <U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent
liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as
now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the
business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current
cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into
account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts
are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction
within one year from the Closing Date. The SEC Reports set forth as of the date hereof all outstanding secured and unsecured Indebtedness
of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary
course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or
not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by
endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the
present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither
the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and
franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other
governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations
and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd) <U>No General
Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any
form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain
other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee) <U>Foreign
Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the
Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff) <U>Accountants</U>.
The Company&rsquo;s independent registered public accounting firm is set forth on in its SEC Reports. To the knowledge and belief of the
Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion
with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg) <U>No Disagreements
with Accountants and Lawyers.</U> There are no disagreements of any kind presently existing, or reasonably anticipated by the Company
to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current
with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations
under any of the Transaction Documents.  </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)  <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <FONT STYLE="text-underline-style: double"><U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity. </U></FONT>Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(g) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted.&nbsp; The Company acknowledges that such aforementioned hedging activities do not constitute a breach
of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj) <U>Regulation
M Compliance.</U> The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll) <U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with
the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common
Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s
stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public
announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm) <U>Cybersecurity</U>.&nbsp;
(i)(x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,
vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;)
and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably
be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are
presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems
and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as
would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented
and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster
recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn) <U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(oo)   <U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp) <U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to
regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qq) <U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(rr) <U>No Disqualification
Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none
of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated
on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company
in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;)
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures
provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ss) <U>Other
Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that
has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(tt) <U>Notice
of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of
(i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably
expected to become a Disqualification Event relating to any Issuer Covered Person, unless such information is available on SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.2   <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   <U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo;
and have not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal
for his, her or its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation
of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation
of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other
persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities
law (this representation and warranty not limiting such Purchaser&rsquo;s right to sell such Securities pursuant to the Registration Statement
or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in
the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8),
(a)(9), (a)(12), or (a)(13) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)   <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)   <U>General
Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over
television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)   <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the
Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the
Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)   <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on
the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.1   <U>Transfer
Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of
counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration
Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   The
Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">THIS SECURITY HAS NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT
IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured
Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal
opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall
be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation
as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including,
if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required
prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately
amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   Certificates
evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while
a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities
Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Warrants), (iii)
if such Shares or Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants), or (iv) if such legend
is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the
staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly
after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser,
respectively. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the
resale of the Warrant Shares, or if such Shares or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with
the current public information required under Rule 144 (assuming cashless exercise of the Warrants), or if the Shares or Warrant Shares
may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information required under
Rule 144 as to such Shares or Warrant Shares or if such legend is not otherwise required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Warrant Shares shall be issued
free of all legends. The Company agrees that following the Effective Date or at such time as such legend is no longer required under this
Section 4.1(c), it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing
Shares or Warrant Shares, as the case may be, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;),
deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other
legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions
on transfer set forth in this Section 4. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer
Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed
by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in
a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend, but notwithstanding anything
to the contrary, in no instance less than two (2) Trading Days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)   In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal
Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that
such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such Purchaser&rsquo;s
total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased
(including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In Price</U></B>&rdquo;) over the product
of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied
by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by
such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the date of such delivery
and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)   Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant
to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution
set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth
in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.2   <U>Furnishing
of Information; Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   Until
the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to maintain the
registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   At
any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy
any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%) of the aggregate
Subscription Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every thirtieth (30<SUP>th</SUP>)
day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure
is cured and (b) such time that such public information is no longer required for the Purchasers to transfer the Shares and Warrant
Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to
herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo; Public Information Failure Payments shall be paid on the earlier
of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>)
Business Day after the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company
fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at
the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to
pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to
it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.3   <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes
of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other
transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.4   <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the
transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under
any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents,
employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any
of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that
each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each
Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and
neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior
consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect
to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with (i) any registration statement contemplated by the Registration Rights Agreement
and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading
Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause
(b) and reasonably cooperate with such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.5   <U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.6   <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such information
and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each Purchaser
shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any
of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not
have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates
or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of,
such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice
provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.7   <U>Use
of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the sale of the
Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s
debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption
of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC
regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.8   <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents, (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions
contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct), or (c) in connection with any registration
statement of the Company providing for the resale by the Purchasers of the Warrant Shares issued and issuable upon exercise of the Warrants,
the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses,
claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses, as incurred, arising
out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the
case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to
the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser
Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection
therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement,
such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof
with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing,
(y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.9   <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.10   <U>Listing
of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading
Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares
and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market.
The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in
such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and
Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably
necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.11   <U>Subsequent
Equity Sales.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) From the
date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii)
file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the
Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   From
the date hereof until the twelve (12) month anniversary of the Effective Date, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the
Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right
to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is
based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance
of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date
after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or an &ldquo;at-the-market&rdquo; facility, whereby the Company may issue securities
at a future determined price; <U>provided</U>, <U>however</U>, that, after six (6) months following the Effective Date, the issuance of
shares of Common Stock in an &ldquo;at the market&rdquo; facility with the Placement Agent as sales agent shall not be deemed a Variable
Rate Transaction. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which
remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   Notwithstanding
the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an
Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.12   <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of this Agreement) shall be offered or paid to any Person to
amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered to all of
the parties to this Agreement. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the
Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not
in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities
or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.13   <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it,
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales,
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules
(other than as disclosed to its legal and other representatives). Notwithstanding the foregoing and notwithstanding anything contained
in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty
or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no
Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade
in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates
or agent, including , without limitation, the Placement Agent after the issuance of the initial press release as described in Section
4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment
decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.14   <U>Form
D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.15   <U>Acknowledgment
of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under
the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the
effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance
may have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.16   <U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the
Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions
and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE V.</B><BR>
<B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.1   <U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.2   <U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.3   <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.4   <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.5   <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded Warrants
based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.6   <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.7   <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.8   <U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company
in Section 3.1, the representations and warranties of the Purchasers in Section 3.2 and the covenants of the Company in Section 4. This
Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit
of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.9   <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.10   <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.11   <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by electronic mail, or otherwise by electronic
transmission (including any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.,www.docusign.com) evidencing
an intent to sign this Agreement, such electronic mail or other electronic transmission shall create a valid and binding obligation of
the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original.
Execution and delivery of this Agreement by electronic mail or other electronic transmission is legal, valid and binding for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.12   <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.13   <U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of
the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and
the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an exercise
of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice
concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement
warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.14   <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.15   <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.16   <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.17   <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
the legal counsel of the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents
the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that
each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and
not between the Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.18   <U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.19 <U>Saturdays, Sundays,
Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.20   <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.21   <B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><B>ACTELIS NETWORKS, INC.</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: line"><U>Address for Notice:</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: line"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: line">E-Mail:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 31%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: line; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: line">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">With a copy to (which shall not constitute notice): &nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">asns</FONT>
SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
__________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory: ______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-Funded Warrants: _______________ Beneficial Ownership Blocker
&#9744; 4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Warrants: _____________ Beneficial Ownership Blocker &#9744;
4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">38</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ea178132ex10-2_actelis.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.2</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGISTRATION RIGHTS AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of May 4, 2023, between Actelis Networks, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each Purchaser
hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">1.  <U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.</B>
As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 45<SUP>th</SUP> calendar
day following the date hereof (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 75<SUP>th</SUP> calendar day following
the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the 45<SUP>th</SUP> calendar day following the date on which an additional Registration Statement is required to be filed hereunder
(or, in the event of a &ldquo;full review&rdquo; by the Commission, the 75<SUP>th</SUP> calendar day following the date such additional
Registration Statement is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified
by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review
and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the
Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on
a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the 20<SUP>th</SUP> calendar day following
the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related
to the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan of
Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Shares, (b) all Warrant Shares then issued and issuable upon exercise
of the Warrants, (c) any additional shares of Common Stock issued and issuable in connection with any anti-dilution provisions in the
Warrants, and (d) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar
event with respect to the foregoing; <U>provided, however</U>, that any such Registrable Securities shall cease to be Registrable Securities
(and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect
thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by
the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective
Registration Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities
become eligible for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as
set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders
(assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which,
such securities were issued or are issuable, were at no time held by any Affiliate of the Company, as reasonably determined by the Company,
upon the advice of counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2.  <U>Shelf
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not
then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate
form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85% in
interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U> and substantially
the &ldquo;<U>Selling Stockholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder
shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent. Subject to the
terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including,
without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof,
but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement continuously
effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement (i) have been
sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without
the requirement for the Company to be in compliance with the current public information requirement under Rule 144, as determined by the
counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected
Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness of a Registration Statement
as of 5:00 p.m. (New York City time) on a Trading Day. Unless such information is otherwise publicly available pursuant to SEC Reports,
the Company shall immediately notify the Holders via e-mail of the effectiveness of a Registration Statement on the same Trading Day that
the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration
Statement. The Company shall, by 9:30 a.m. (New York City time) on the Trading Day after the effective date of such Registration Statement,
file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such
notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the
Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single
registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts
to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities
permitted to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities
as a secondary offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and
subject to the provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior
to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration
of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation
612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d),
if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a
particular Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with
the Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a
Holder as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be
reduced as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">Second, the Company shall reduce Registrable Securities represented by Common Warrant Shares (applied,
in the case that some Common Warrant Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered
Common Warrant Shares held by such Holders); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify">Third, the Company shall reduce Registrable Securities represented by Shares and Pre-Funded Warrants (applied,
in the case that some Shares and Pre-Funded Warrants may be registered, to the Holders on a pro rata basis based on the total number of
unregistered Shares and Pre-Funded Warrants held by such Holders).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In the event of a cutback hereunder,
the Company shall give the Holder at least three (3) Trading Days prior written notice along with the calculations as to such Holder&rsquo;s
allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its
best efforts to file with the Commission, as promptly as allowed by the Commission or SEC Guidance provided to the Company or to registrants
of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable
Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein or the Company
subsequent withdraws the filing of the Registration Statement, the Company shall be deemed to have not satisfied this clause as of the
Filing Date (i)), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in accordance
with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5) Trading Days of the date that the Company
is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo;
or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file
a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement
within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order
for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable
Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement or (v) after the
effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to all
Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein
to resell such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar
days (which need not be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five
(5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded, and
for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by
such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages
and not as a penalty, equal to the product of 2.0% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the
Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after
the date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to
be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus
all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata
basis for any portion of a month prior to the cure of an Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register
the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form
S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in
effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the
Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any underwriter without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3.  <U>Registration
Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Company&rsquo;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior
to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex C</U>
(a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing Date
or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance
with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and
the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable
Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in
order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended
or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to
be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect
to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies
of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information
contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply
in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of
all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this
Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in
such Prospectus as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common
Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior
to the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of
such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be
accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably
possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person)
confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement
or post-effective amendment to a Registration Statement is proposed to be filed, unless such information is available on the Company&rsquo;s
SEC Reports, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo; of such Registration Statement
and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement or any
post-effective amendment, when the same has become effective, (ii) of any request by the Commission or any other federal or state governmental
authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii) of the issuance
by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration
Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv) of the receipt
by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable
Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of
any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein
or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference
untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the
case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect
to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest
of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>, <U>however</U>, that in no
event shall any such notice contain any information which would constitute material, non-public information regarding the Company or any
of its Subsidiaries, and the Company agrees that the Holders shall not have any duty of confidentiality to the Company or any of its Subsidiaries
and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis of such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the
effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the
Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto,
including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent
requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR
system (or successor thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement
thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus
and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the
extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations
and registered in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) Upon the occurrence
of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company&rsquo;s
good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare
a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus
or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter
delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which
they were made, not misleading. <FONT STYLE="text-underline-style: double">If the Company notifies the Holders in accordance with clauses
(iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been
made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus
may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j) to suspend
the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required
pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration
of the resale of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common
Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive
control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration
of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">4.  <U>Registration
Expenses</U>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by
the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to
in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees
and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with the Commission,
(B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C)
in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation,
fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities),
(ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger,
telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the
Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation
of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred
in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses
incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall
the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction
Documents, any legal fees or other costs of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">5.  <U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold
harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred,
arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any
Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or
relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2)
any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or
regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the
extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the
Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s
proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly
for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has
approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi),
the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing
that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of
the Advice contemplated in Section 6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of any
Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware, unless such
information is available on the Company&rsquo;s SEC Reports. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in
accordance with Section 6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such
Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in
the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex
A hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder
be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating
to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission)
received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification
obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in">An Indemnified
Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in
writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding
and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding
(including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party
shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified
Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to
employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).
The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent
shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in">Subject to the
terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent
incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall
be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that
the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions
for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal
or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to
hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such
Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party
in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material
fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo;
relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount
paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement,
any reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such
party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such
party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The parties hereto
agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission)
received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The indemnity and
contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified
Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">6.  <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each
Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any
of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of
such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Except the shares of Common Stock issuable
upon exercise of the warrants issued to the Placement Agent in the transactions contemplated by the Purchase Agreement (if any), neither
the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company
in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration statements until
all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided
that this Section 6(b) shall not prohibit the Company from filing amendments to registration statements filed prior to the date of this
Agreement so long as no new securities are registered on any such existing registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject
to the provisions of Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be
in writing and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of
clarification, this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment,
modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately
impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities
pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered
for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable
Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions
hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be delivered as set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall
the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with
respect to any of its securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by e-mail delivery of a &ldquo;.pdf&rdquo; format data file or any electronic signature complying with the U.S. federal ESIGN Act of 2000
(e.g., www.docusign.com), such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be determined in accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not
be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Independent Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not
joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose.
The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the
action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and
a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>ACTELIS NETWORKS, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO ASNS RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Signature of Authorized Signatory of Holder</I>: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory: _________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title of Authorized Signatory: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Plan of Distribution</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Stockholder (the
&ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest may, from
time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange, market or
trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling
Stockholder may use any one or more of the following methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the
block as principal to facilitate the transaction;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>privately negotiated transactions;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>settlement of short sales;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a
stipulated price per security;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>a combination of any such methods of sale; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>any other method permitted pursuant to applicable law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in
compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling
Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them
of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>Annex B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The common stock being offered
by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders, upon
exercise of the warrants. For additional information regarding the issuances of those shares of common stock and warrants, see &ldquo;Private
Placement of Shares of Common Stock and Warrants&rdquo; above. We are registering the shares of common stock in order to permit the selling
shareholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the warrants,
the selling shareholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders.
The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of
the shares of common stock and warrants, as of ________, 2023, assuming exercise of the warrants held by the selling shareholders on that
date, without regard to any limitations on exercises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of common stock being offered by this prospectus by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the number
of shares of common stock issued to the selling shareholders in the &ldquo;Private Placement of Shares of Common Stock and Warrants&rdquo;
described above and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants, determined as if
the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially
filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment
as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The fourth column
assumes the sale of all of the shares offered by the selling shareholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the warrants,
a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together with its
affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99% or 9.99%, as applicable,
of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable
upon exercise of such warrants which have not been exercised. The number of shares in the second and fourth columns do not reflect this
limitation. The selling shareholders may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name of Selling Shareholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares of Common Stock Owned Prior to Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares of Common Stock Owned After Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Annex C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Actelis
Networks, Inc.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Selling Stockholder Notice and Questionnaire</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Actelis Networks, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale under Rule 415 of the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in accordance with the terms of the
Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this document is annexed. A copy of the
Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTICE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned
by it in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">QUESTIONNAIRE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B>Name.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Full Legal Name of Selling Stockholder</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 83%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Registered Holder (if not the same as (a) above) through
which Registrable Securities are held:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 83%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Natural Control Person (which means a natural person
who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 83%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>2. Address for Notices to Selling Stockholder:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 14%">Telephone:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; width: 86%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">E-Mail:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Contact Person:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>3. Broker-Dealer Status:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Are you a broker-dealer?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Yes &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities
as compensation for investment banking services to the Company?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> Yes &#9744;   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">Note:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;no&rdquo; to Section
3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Are you an affiliate of a broker-dealer?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> Yes &#9744;   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If you are an affiliate of a broker-dealer, do you certify that you purchased
the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold,
you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> Yes &#9744;   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">Note:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;no&rdquo; to Section
3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>4. Beneficial Ownership of Securities
of the Company Owned by the Selling Stockholder.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Type and Amount of other securities beneficially owned by the Selling Stockholder:</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>5. Relationships with the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">State any exceptions here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees to
promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify
the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus </FONT>and any amendments or supplements thereto<FONT STYLE="font-size: 10pt">.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of
the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>Date:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
    <TD COLSPAN="3">Beneficial Owner:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE EMAIL A .PDF COPY OF THE COMPLETED AND
EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">C-3</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ea178132ex99-1_actelis.htm
<DESCRIPTION>PRESS RELEASE ISSUED MAY 4, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>Actelis Networks Announces $3.5 Million
Private Placement Priced At-The-Market Under Nasdaq Rules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">FREMONT, Calif., May 4, 2023 &mdash;
Actelis Networks, Inc. (NASDAQ:ASNS) (&ldquo;Actelis&rdquo; or the &ldquo;Company&rdquo;) a market leader in cyber-hardened, rapid deployment
networking solutions for wide area IoT applications, today announced that it has entered into definitive agreements for the purchase and
sale of 944,670 shares of its common stock (or common stock equivalents) and warrants to purchase up to 944,670 shares of its common stock
at a purchase price of $3.705 per share of common stock (or common stock equivalent) and associated warrant in a private placement priced
at-the-market under Nasdaq rules. The warrants have an exercise price of $3.58 per share, will be exercisable immediately upon issuance
and expire five and one-half years following the issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">H.C. Wainwright &amp; Co. is acting
as exclusive placement agent for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The gross proceeds to the Company are
expected to be approximately $3.5 million. The offering is expected to close on or about May 8, 2023, subject to satisfaction of customary
closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The securities described above were
offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) and
Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under
the Securities Act or applicable state securities laws. Accordingly, the securities may not be offered or sold in&nbsp;the United States&nbsp;absent
registration with the Securities and Exchange Commission (SEC) or an applicable exemption from such registration requirements. Under an
agreement with the investors,&nbsp;the Company&nbsp;agreed to file an initial registration statement with the SEC covering the resale
of the securities described above no later than&nbsp;20 days following the date of the agreement and to use commercially reasonable efforts
to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than 75 days following
the date of the agreement in the event of a &ldquo;full review&rdquo; by the&nbsp;SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">This press release shall not constitute
an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or
other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities
laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.35pt 0pt 0"><B>About Actelis Networks, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Actelis Networks, Inc. (NASDAQ: ASNS)
is a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT applications including federal, state and
local government, ITS, military, utility, rail, telecom and campus applications. Actelis&rsquo; unique portfolio of hybrid fiber-copper,
environmentally hardened aggregation switches, high density Ethernet devices, advanced management software and cyber-protection capabilities,
unlocks the hidden value of essential networks, delivering safer connectivity for rapid, cost-effective deployment. For more information,
please visit www.actelis.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Forward-looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This press release contains
certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. These statements are identified by the use of the words &ldquo;could,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;may,&rdquo; &ldquo;continue,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential,&rdquo; &ldquo;project&rdquo;
and similar expressions that are intended to identify forward-looking statements, and include statements regarding the completion of the
private placement, satisfaction of the closing conditions and use of proceeds therefrom. All forward-looking statements speak only as
of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our
plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give
no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant
risks and uncertainties (some of which are beyond our control), including, but not limited to, market and other conditions, and assumptions
that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results
to differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly.
Forward-looking statements also are affected by the risk factors described in the Company&rsquo;s filings with the U.S. Securities and Exchange
Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether
as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence
of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">###</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Sean Renn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Global VP Marketing &amp; Communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">srenn@actelis.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matt Glover and Ralf Esper</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gateway Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 949-574-3860</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASNS@gatewayir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B></B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>ea178132ex99-2_actelis.htm
<DESCRIPTION>PRESS RELEASE ISSUED MAY 8, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="ex99-2_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Actelis Networks Announces Closing of $3.5 Million
Private Placement <BR>
Priced At-the-Market under Nasdaq Rules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>FREMONT, Calif., May 8, 2023 &mdash; Actelis
Networks, Inc. (NASDAQ: ASNS) </B>(&ldquo;Actelis&rdquo; or the &ldquo;Company&rdquo;), a market leader in cyber-hardened, rapid deployment
networking solutions for wide area IoT applications, today announced the closing of its previously announced $3.5 million private placement
of 944,670 shares of its common stock (or common stock equivalents) and warrants to purchase up to 944,670 shares of its common stock
at a purchase price of $3.705 per share of common stock (or common stock equivalent) and associated warrant priced at-the-market under
Nasdaq rules. The warrants have an exercise price of $3.58 per share, are exercisable immediately upon issuance and will expire five and
one-half years following the issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Actelis expects to use the gross proceeds from
the private placement of approximately $3.5 million, together with existing cash and cash equivalents, for working capital and general
corporate purposes. The Company may receive additional gross proceeds of approximately $3.38 million if the warrants are exercised in
full for cash. There is no assurance that any of the warrants will be exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">H.C. Wainwright &amp; Co. acted as exclusive placement
agent for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities described above were offered in
a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) and Regulation
D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Securities
Act or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States absent registration
with the Securities and Exchange Commission (SEC) or an applicable exemption from such registration requirements. Under an agreement with
the investors, the Company agreed to file an initial registration statement with the SEC covering the resale of the securities described
above no later than 20 days following the date of the definitive agreement and to use commercially reasonable efforts to have the registration
statement declared effective as promptly as practical thereafter, and in any event no later than 75 days following the date of the definitive
agreement in the event of a &ldquo;full review&rdquo; by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction
in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any
such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Actelis Networks, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Actelis Networks, Inc. (NASDAQ: ASNS) is a
market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT applications including federal, state and local
government, ITS, military, utility, rail, telecom and campus applications. Actelis&rsquo; unique portfolio of hybrid fiber-copper, environmentally
hardened aggregation switches, high density Ethernet devices, advanced management software and cyber-protection capabilities, unlocks
the hidden value of essential networks, delivering safer connectivity for rapid, cost-effective deployment. For more information, please
visit www.actelis.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: #FEFEFE"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Forward-looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This press release contains
certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. These statements are identified by the use of the words &ldquo;could,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;may,&rdquo; &ldquo;continue,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential,&rdquo; &ldquo;project&rdquo;
and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the
date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans,
objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance
that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties
(some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience
and present expectations or projections. Actual results to differ materially from those in the forward-looking statements and the trading
price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in
the Company&rsquo;s filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update
or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date
on which the statements are made or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: #FEFEFE"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matt Glover and Ralf Esper</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gateway Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 949-574-3860</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ASNS@gatewayir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  G '8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZHYIX;=-
M\TJ1)G&YV"C/XU4O-9L+"_M+*YG"7%T<1+@G/^%>'_M ZO+JFN:%X0LSND9Q
M-(H[NYV1C\MQ_P"!4VFM6)-/8]ZAN;>Y#&">*4+U\MPV/RJ6OG#X422^ _C%
MJ?A*[ES%<[K=6/ 9U^>-OQ4G_OJO>?$7B72/"NEMJ.LWB6UN#M7()9V]% Y)
MI#-:BO/-*^-G@O56N5CN[F V\+3-Y]N1N5>N,9R?:O+M+^-FM'Q_=;K][S1I
MII$L[=X%7[S8CS@;O3O5*+=A-I'TFQ"J2Q 4#DFN0UGQ7I_G?V?I5G'JFH/\
MJJJ!D4^Y[_YYKB?%>OR6!B_X337#8K-\T>G6B;Y67UVC@#W8UTGP\\7^!M6D
M?3_#TC17P7+1W4>V:0#J0>AQZ _A71RTZ>K?,^RV^_\ R,.:=3967GO]QL:'
MJ6EZ"EOH&H:Y9G6'?)MFG&\,_(15ZXY&*Z.6]M(+F*VENH8YY?\ 5Q/( S_0
M=37SMXN_Y.@T[_K\LO\ T%*WOB+IOA>Y^,6D3ZCXBN[._4VX^R):L^[Y_DVN
M.%R>OIUKGE)R;;-XI15D>Y45R/B[XE^&?!5S':ZM=R&[D7>(((][A>Q/8?B:
MF\(_$#P_XW$XT6XE>2W :6.6)D90>A]/R-2,ZBBBB@ HHHH X2WO=3L;FXN=
M6\-3W=XLK2)<H59(T'0*3]T 5XGX6N]3\=_&NX\16EB+IH)&NDAD?"HB_)&"
M?;Y?Q%?3VHV,6IZ;<V$[2+#<Q-$YC;:VUA@X/;BN?\(?#WP_X(DNI-&@F1[H
M*LC2RESA<X STZUK*HI-.WYF4:;BFKG@_P 8+7Q!HGC32_%=U!#:74VTQM;M
MD"2(C&>O."OY55^+LFHW4GAK4-0U.2^T^^M?M$3*,*FX@L .F<%:^C/%G@W1
MO&NGPV6LPR210R^:ACD*,&P1U';!JE/\-_#=WX0M_#%U:RSZ?;$F R2DR1$D
MG*OU'4_AQ4N=[V6Y2CMY&!X8\*?#*9[1-+>PU">6 M&GG!G,?&[<H^HSN%>9
M?#_3+"3]H/5+-[*W:UAFNC%"T8*)M;Y<#H,=J]>\'?"CP[X)U:34]->\DNFC
M,0:>4$*I()   ]!5[2OASX?T;Q;<>)K2.X&I3M(SLTQ*Y<Y;BE*3ENQJ*6QX
M5J4>MWG[0VHI;W5C;:F+AQ:OJ2[H@H3Y  0>=N,>];X\"^);KXH6&J7OB7PT
M-;MY(II+>VD\N1T!Y^0*,DC(^E>F>/? ?A+Q':2:MX@C:V:SB+O?0,4=8U!/
M. =P'T/M6)X.\$?#WP]K.E7^G7<E_J.H1/-I\MS(9-RJ,LR@  $ ]^:DHX#Q
M=_R=!IW_ %^67_H*5'\5_P#DONC?[UE_Z,KV:_\ AMX?U+QG%XKN%NO[3BDC
MD4K-A,H %^7'L*BU3P!X6\4^)T\0SM)/J%G(D9,-Q\J/&<A6 Z$9&10!P'Q!
M\&OJ_P 1Y-;\->(-+77+,1&?3[UU!4A1M(# @@KC@C'O6A\'O'#:[K^KZ3?Z
M-I]IJL4>Z:ZL8PJS[&VX8#()!;@@X/-=#XI^#?A7Q7JLVJ72WEO>S$&62WFP
M'.,9(8$= .F*V/!OP^T#P-!,ND02>=/@2W$S[I' Z#/  ]@* .IHJCK.KV>@
MZ1<ZIJ#M':6R;Y652Q SCH.O6KD;K)&KKRK $?0T .HJ&6[MH'V2W$4;8SM=
MP#C\:* )J*** "BBB@ HHHH Y[Q[%)/\/O$,42[I'T^=5&<9)0UYEX3\-ZEH
M/Q \(09WZ.;&:ZMP7!:W>6$>;'UZ;QN'^]110!H>&)]9?XO7MM?ZO<"YCFN7
MFM,%HGMCCR>=^T8X(PN>N>M/TSP_?6_A3Q[_ &=/=07RZU/<VK_:#\WE['7)
MS_%@J<]0>>E%% $_@"/Q5?\ B22XUN[?R;>T-U%&)LJ9+K#[6 /(C *CZ\54
M^%MQKD_BV]BN[K4)6MK=X]86[N%DC^V>9E/) )PNS/3 Z"BB@"&'2=0?X#ZS
M=7EW?7FI7\#!TN;C>$"RL%5,G &.O/-6]-N=1@\ ^+H=8OK^#6X';[3<P2!Q
M&C >68%W *H7^'(/7OBBB@#;\ :;8^(O NGW.JZ<DYRXB>>1IBZ;CA@7)8 ]
*=I)QTHHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>asns-20230504.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K4ps7xRiXgOn8uBan0sSaiGKcP9wZ1yiZkxvW93bRk6jy8tqoXu7yMUtgSmUXIJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ASNS="http://actelis.com/20230504" elementFormDefault="qualified" targetNamespace="http://actelis.com/20230504">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://actelis.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="asns-20230504_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="asns-20230504_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>asns-20230504_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>asns-20230504_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://actelis.com/role/Cover" xlink:href="asns-20230504.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://actelis.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140516688937248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 04, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  04,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Actelis Networks, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2160309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4039 Clipper Court,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fremont,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">545-1045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASNS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>ea178132-8k_actelis_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asns-20230504.xsd" xlink:type="simple"/>
    <context id="From2023-05-04to2023-05-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141284</identifier>
        </entity>
        <period>
            <startDate>2023-05-04</startDate>
            <endDate>2023-05-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-04to2023-05-04">0001141284</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-04to2023-05-04">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-05-04to2023-05-04">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-05-04to2023-05-04">2023-05-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-05-04to2023-05-04">Actelis Networks, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-04to2023-05-04">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-05-04to2023-05-04">001-41375</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-04to2023-05-04">52-2160309</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-04to2023-05-04">4039 Clipper Court,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-04to2023-05-04">Fremont,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-05-04to2023-05-04">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-04to2023-05-04">94538</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-05-04to2023-05-04">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-04to2023-05-04">545-1045</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-05-04to2023-05-04">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-05-04to2023-05-04">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-05-04to2023-05-04">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-05-04to2023-05-04">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-05-04to2023-05-04">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-04to2023-05-04">ASNS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-04to2023-05-04">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-04to2023-05-04">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-05-04to2023-05-04">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M\D0#P=&M.+JG)6,&2LB83;*88>TUYH56LE54EE%;'5U6:)>DX"0SPFS9O4B
M38MTT5S:M(;G^>>AW[GJ$CQ7%<_5*3Q/L!*VLC%G4YXV)HK6&44&$J'9%$SI
MUV?L(8LN",!>!=@[!7",PZEX@JHQO+&/L&U"I)4\S)L?^D$O)+"N*ZSK4[">
M^1M[B)%-+$7$2Q<_/JJT8C<X#] ,.MXU@>=[M6MZIP#B*$B52U6RG;&YP6G
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ <(&H5I>*NQS
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M7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ <(&H5B0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !P@:A6K;I0$NX    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !P
M@:A6F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( '"!J%;!FS8*< 0  "L1   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !P
M@:A6GZ ;\+$"  #B#   #0              @ &S#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( '"!J%:7BKL<P    !,"   +              "  8\/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( '"!J%:JQ"(6,P$  "("   /
M          "  7@0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !P@:A6
M)!Z;HJT   #X 0  &@              @ '8$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " !P@:A699!YDAD!  #/ P  $P
M        @ &]$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(   '%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea178132-8k_actelis.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://actelis.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea178132-8k_actelis.htm">ea178132-8k_actelis.htm</File>
    <File>asns-20230504.xsd</File>
    <File>asns-20230504_lab.xml</File>
    <File>asns-20230504_pre.xml</File>
    <File>ea178132ex10-1_actelis.htm</File>
    <File>ea178132ex10-2_actelis.htm</File>
    <File>ea178132ex4-1_actelis.htm</File>
    <File>ea178132ex4-2_actelis.htm</File>
    <File>ea178132ex4-3_actelis.htm</File>
    <File>ea178132ex99-1_actelis.htm</File>
    <File>ea178132ex99-2_actelis.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea178132-8k_actelis.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea178132-8k_actelis.htm"
     ]
    },
    "labelLink": {
     "local": [
      "asns-20230504_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asns-20230504_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "asns-20230504.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ASNS",
   "nsuri": "http://actelis.com/20230504",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea178132-8k_actelis.htm",
      "contextRef": "From2023-05-04to2023-05-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://actelis.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea178132-8k_actelis.htm",
      "contextRef": "From2023-05-04to2023-05-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001213900-23-037340-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-037340-xbrl.zip
M4$L#!!0    ( '"!J%9G@YP=*0,  *@+   1    87-N<RTR,#(S,#4P-"YX
M<V2U5=MRVC 0?6YG^@^J7SN^06X02"9-)AD:<AE<4B8O'6$+HB(D1Y*Y_'TE
MV>9J*-#63]+N.6=WI5VY=CD9$C!"7&!&ZY;O>!9 -&01IOVZU0[LJ^"ZT;#
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M#02DDOME9"DP2Q,U@/5"TI8Z/]T S+9./0Q=4)P YN!3DDKOEY3%(Z%4W0_
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M:R#Q/U!O/#P:D9"/9I1SE\ 1 >KE5?9 [']B8O?K? 7@KY_=]=U>6N#LMXH
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M+N[+S)Z/J[Y,@D-Z34%H.%#RS1=(1PG*99)87'K]YX8)V@N%HM(</$>$%X"
MS%>"_?AEV(_AV%'RT%J9KP3[R<NPG\"QH^2BM3(QL??MQSOU*!>>&6BO,10Y
M2BY:(Q$3>'ZEN5/W2CZS8D54'?6#$E#TB"EJ6"QJAR\N\I#>7EI">2.FJ]7B
M,#G?2VT(_X_-Z^XDJ^VAS!$3UY#0IA\P%G%W#RU\2XGV3*!\47+52CE-(W41
M5I3XN^^N!10H2@):):9AGC?2S7W,I @^CSVT@G)%R21]HIH>>-TZ8NT]];>^
M!J]@0QE6]V4TC/&[8L9ZT)=IFHGU,QK/K)C'%(H7)?T+RFL8]4AR%C/#Q/2+
MO4-4C/!JSE5V4,@HR9Y?6,.$[Q5UD:;VMCM?Q^4V&JB[R<0W\H;LH<11<KUZ
MH;CDAUIG5+V4?T4I:!10TCZHZ*;'&1IG=MA;]8['CV['C&>4.;""LD9)^7RB
M&F9[*Q\5<3OU1JMT++E_>TBE(90P2H(7D-8PY!T_JO'NF4#!HF1VE7*0QH3K
M93PC8DK]JQ>J+:& 43*]D#BTL7<*&GNG+QQ[43(^GR@DML7:<'M&W8TYFQ+_
M3K)@ ? ^&TSB :E-[]_+M_RX/=PJS?T8V _5V#VF4. X6R1#\II&G27,T*1P
M:< $$;%-J3;[VCS9>7TI: !P]E "1:,\WO]..?\LY$*,*-%2T*2XU0\]X?<6
M@48!<0ZQ1BY*"+Y)GEE**E\(JCSG@,<4BAQQ[M C#V?M9;&H>7/M*5[6$2+N
M*P$%CSB)&!:+M#[-4.<S>Z8?B2%K#T/\?26@_!$G%,-BT=;/J[Z]\$QE>,Y\
MSQ!*&W$I;*4T%,BCE'!^E6DFJ Z.+7N&4,B(:UXKI:% ODZIFMI![9.2"S-;
M[^T,P?84@$)'7-D:E(H#?_ES'WFQ_RU(OL(:_'8"1.Q>D5BOW8ACMY"BN)*+
MA"@/]9 ]E#OJQDJ_T(;)WYD95=OW3[DS0YNWA18]U)>"1@$E786*QKFV;NWD
M#UY:=^R@O!$3TRIA.'NFLC%G\8!+$KPOWS&#\D7,0BMDH>"](N))97,3K^Z5
MC"EUTR=Z<[8!$B)@!="0(.:G+T*!\[A IJG;3"3CI]',BM9WF<G?76K]"SXT
M"):#A@9S$R= .-)=D/ZYT8LF5ZL'.J'*+5-XI$MS91MZ"M\4 8I#XX/Z1B$P
MAHHPG7</=-W8 ^[MM,4W[I=[ ZL]\C]02P,$%     @ <(&H5AIXY1*C&P
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M]JI>OX$_"![+Y=;M76G>XDIO8RN\#5;XB&&JY;#7MW2O56\%\!: #_]K6H#
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M>I.DS'SG:+I"ZGQJ-@?P:^N+4(!?X/IGW!<GT1*"D:)W"]V E$LZ!6_FP4H
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M2)LW<U*7J2Q @3^QW3M8>LO2\C^:7=EI3CGH)5R,%-!@$8Q[S'.$A@&SS@S
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M98P9(YA++I5\OT6LSYU$CP>(<:J6RBEDW2./SDERP<+9\.#,_P( KN!WN9X
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M4K<SJ=JE)9+0B"G*+JOF#P__9#L("U=@QVT>[:6V'9I^CDJ'V!-T?=)>!)U
M<R,U[+%/82UR54+%1LR60%46X9+;M$GU@"YT0%W04JBA+I"&>'<6@K1$?Q.0
MR&0(<HQ@P2 AT21"B-\PQN^). -M+C?UT^BB19>)(GYN6$!05X E]^"9+(MG
M S022^)@(RLZ]4;ZA3@[MBM9@_D!9/"DD;:4/>%J5W*0& 3"CETA348*--ST
MP&E2^1$0NB$'&^6->Y_!%*-8:,)%:(F['04FYE=,ME=D.I^A?/E*&0BP2&3
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MZ]?O6&G <B^R&0R<PC/HQS71X:-#\ >K!CPH^,!94Z4I*(OG)8@-F-8O8$#
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MVG%H$< W5LJ>@J&]<S\P%M7XC<MDSG*=8DZ(W[L%9 ^AET,DFAZKTLE%%89
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M37G&2) >^Y0;'H2R E.&/K8JJ<B.RN&H8(]D9C%7[H&>81/6\3K%WCXUR[<
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M@TMC0/8XTAQ'-,G;2G[&RC*@"P\_>T &69<UOF$)J3SV1:NT@+.$ L%(GN[
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M="V=9%RM@CDI5,+\(64%S.DWJXD=YW ?JGJ+TM_*TEWX6H[QJ(W-4<3I4;L
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MIKZBR1E))HSUXK#44UU<>*#P%>N%V"I@8CQ8,;RJFL42-ZG'>B>91Y,F"<O
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M9D(B0.JW";+>BN]!20K(C,7'LVC4>W_0>HD&O@,N3@G-V5;MT\0,Y*)C1/I
M"W(FS&V%*VB"@#S0E >18C5C65,+4P!]P?GR[L::!$5$;MME%,IPUXGW@Y\*
MA>'P5\[:TH-3R'W]OI;D6AL'$P],@1](GZ013-N$GO=P;,)3RX>>/$KUQ>SX
M#@#C?_=-M[C?G6G'H,+/_-U,=_;AL[V]U3O=^D)XEK$8,.>1/8!7 1A.BY&6
MZ3^&6E'0K^ FY1+3"\2Z84KCT[IM,4'A8A:$_5/@YJOB.65\X?]K;,&%;AOX
M#,-=X?<MQY>&V< G3MU-_F\YON!V9FH<:!6$Z\]:O-*R64 R4RYH"+&="U4W
ML_*F9=<@F\B6H8]#'(=4ZW(X:Y@2+4Z<'>S@;Y<"$40D-G5.N%@/RK@@,X6]
M$7!T4VH%:T7 ;-)0>7=B*^:1*&-N%!ES$X77)A,::C=K]U@L^XCCJ&RE/9U^
MRZA&(@J%RE /\)4+"+#BZ.^8F-Q9)A*<Q@)P2E'8?LFYKJJQ3*V!Y#!0)L(\
M>[+KR)M#8\%M<;'D6.KMI*O&B>PDEIUOEY[,'@B>$GGK1](ZX=P, *<3_1'"
M4 J?)?6O.C7,/DU/R(1Z/4X,<>7]KTF=R]2;-2*Y=#$@'6/KUS,F;C2!2>8E
M>"ET<?55VP1CS;$0RI.2'?05I(7LY&J0/EZZE]1W*<P)$^U/1194&%.AIEP2
M4H0J%D:Q>=(4RW&>733./ '<V9DC=*IJ8FN8+*>9B\#YWDS\/-I)<MQ'!5JD
M8%ZH=V]7*>4Q6.2>=[40^\2HF!1)L##ZH4, .":P6[BD^GAX\T C-G8X(C^#
MMP8[,M"]  T1G)3QU=/SFRA_DXO5]X8@>0*(G5?#'AP)9&4?K$EDK3/8.]$Y
M@:R+U 7C_D%DKL[@+?'=Q/:7R^WN_&B6HM117F#!&'\3O%BSBR&6#65Q66TA
M5;;/&3PBO!R4?@2X B1RH"'84W:08<;)! D P5T8.0))Y/M/SJ&)XI)"7W\I
M,KI,9IM\?,*EU18AP4_O?]=]ZJCO&9]R3*.BYC^W5YQ1+$B]$%$_& '+;+3Z
MV0?2$CXRF)UP+KK/G<O!-<5N%FF@JAIG[XBE4DPBE8X62$4"#-YP-.X0'6S5
M3LN"EAP#;Z05F]8^\62B0&< >,A-HCM>(3C>VE,U-26? 'P<X*Y-IQY#*[>]
M169N0I0'R7I,/R4:?9<93Z>XQB011$PJTE ;V&W[\O67"#<*TJ)I*IK8H18[
M3O8^-/+J"D!;!*U'R670$.G=13*A"R^OLC^Q'HGF,<^;>@GKP9JC>%+"SA9:
M'FP:^;C##FR\3J?'T$N*=!B@CE-X*TCP3CI^&+_&OI[C;JL6$K SPJN<@(FC
M:0)G$@\C(V4#$6-][6;N?4U L)5JI='X=[-!8LKZAD5QCGNWJ*M2>OU4-DG6
M(R*BJD;8WF3_1H]#6PZ/(?'"Q::;L(5%6N6M<_F!/X@>=L]VX$W>*3H\^(V0
M4?1 WM"X6T+'.3:;2RL;$48MW1'55/_L E/,Z]W>>G"S$Q;/W,6@U[$4S'EA
M#S9F'H#]Q7I5_-ZYLYIFBGDN>.[UQ;O]_,\=/8(*(T@$/I+:2W,[HX?$5\FM
MF8?*@3OL%\*<IG\@M*=%6R#[<S>+J\M;_HZQ>MHO7P< PR)%ZXQGJZH>T>,D
M%\S,G3W4PP2 E%DISBNO6'GPL(:"WA*K3(&K0KLE94N2ZK% MB \"";C&_&_
MXP6VMZBH4H9T#PGJZ2[Z4*"F/OU^7H8HTP3$]'M<*$\B!)];J>F3CF-==.4X
M7A<WCM@BI*,?,%0+PC"MF"^??+]-I&N#G?6A;G+'=V+>[%8A+RV'*DX"KE"L
M_=8O4QD0[69H?96V8R$L(&(",3"&>B2L6(19!WR': %R4NUR*QV%2=P;F+;<
M[0Z8*A)?LVW@P>,L@B#0.Z]!FS(1BE@."@KDE^RA>893P:,UXH>EMHE-$YCB
M*KZ!5EL$3%00?%*.9)]OM<<RU)$_H^K'?2:SOZ-D]HG;5,V53V3;6A6EL@>Z
M-@V!3=XYN1J\$,>A71--:;QE25IM^%'\),)]?&,YL=] ?A*?491&YK FY]0-
MCL!'.(P@D>8<!MBX:^EEY4C@VB3"^<$.QE5]E3H2,9I^)R]+"'[%4(2^"/QS
M6I1K2G+?;4IR4I+[;E.2NV\K]O@1F;&#JEU(O:=KPJS_QA U :75&/F>8TYK
M,D'6MHB.#N45,4'29,Y!$7&8?IKZN)>A%N^U6C#?":!UIC=XX9+;X)Q]]'_P
MD!]JUTDA-R#;AO:*U!]I;&7 '<8F+&&G:HX$(FX!%H^BZ)3$/L,9F'2OGS*#
MZ<M'G!32ED=OHL,=AME$>D,:6X:,X0#P&$L H@Y;T*7#<E#PY9GV"(' "\5!
ME+"D"/06ST5OBBX(.2M/H:!Q+#+:!-DM\HN2E]_>BAFR:XHJ4+%.7NE8IS/U
MC$C/):\,?G;.. 1!B: %)P$'CNMGQ!DFB0B@J\^.6P]LLP#P;.?[<S:APZ.=
M6E1X?Z2@0[>;"?@AS=(E2_;P'N4MS*4KR9";QQVT>(GS&RD2$*4&3WFT#I-:
M9=&F)XE(C%^4IJ/C4913]P1-/7-^O*&XPC03?J%7^@@#0'H09WG #\$DWFA:
M%@TAZYR;TG!VV^K@IK+?YS?"=63@3Q-^J'7#, MKW4CBC)MO@$K,PYU[.'\N
M#SL^AAYS'Y,RGVQO#8D/Z;1P"W&7V/3_Y;DUBQWB5<"4ON7#9+V2ZC>@$/KZ
MT0Y2W65]<J%YMJH!61&YRG51L6Q)GJ$/",0]-:%W?8.0>OYX%=)/I$A;N0%0
MR72.K266,(#/Y%38L0+\)TGV[2TBPNCOZ)3J[.IB#V;),'%"I9*%@B*+J)TF
M4L<&V/"*]M -)2Q3PL+"I0)0=^$B0N"ZG(*ZS^,G*SA@XW6<S&6Z58:$)B7S
MTGML-?8\+E"P&:#5N(JS8 US5Q\FFV6-=KHC^UL0/F#]/L .!]/%B.?D<J9$
M+/4$4LY7]?2*$$@_NWM@D'\"\V=R:[L&3]3[H:ZD7V%!&3Y'O+!4)[KUJ518
M8C8,FDP .0RS24;:%* HJ=E@K],5" + 8&"JL0Z(!2Q*D#<2W1><<^XTHF.J
M ID!./F6:]:LF/:*Z9!A V$5S*[2, CU#_HEN4\JL)Y)HP-C?L)&^1ZJ$;-X
M@E:J!YN@(PLL>U?TVN$DSP7F@IX2?K7E>K!&/>TZK1K&/I&6J^?-<6M":@.P
M('VFO_\U@'5\M2-8.#\)YO'M@P>/:K.!YR55N0 L#V79^E)(?7$;6TGJ>)C9
MZE'B1E(&F7I$X=O(,AN2%Z\(-B+N5LSF](86C/P+'%ZRT.RW*0H]JISP.V!9
M*4/Y'&Q<K."BM6AY_=9"?1+O'=;,#C! .1@815VP)B3YG3A").3E&7&^.3XV
MZ86R> COZ6+QT(WN(0U6-O"D&*%KC3PW&(_'.5TZBUNK\[9 4"2].H_@P3?_
M/3A?TA $EB*'7[ROKX&)E_X-:R/G11E0=;<K)8KSR >88 ]A:NV3X)<^M7E%
M\5/[D"?JOL*NC@*Y "]"@A#?8^WMJ#NX.X8T+-!V>7$!%$*<]QV"S60B'O+I
M;G6B2=.BK<Q&+C K9 B]65D>T++PR$TV[$W&^VS<BY< (<NRB":%/(V )R64
MF7EB5@?E@F)6SFR(\CW9OKXNJ7%C=W/=?R";ZKD[U:/+_'5RUT\?;7+7G+M^
M^FB3N[[WW#7KU@R!QGY[Z\S-Y4+2-W$_R2'A5"L Q>(.C4A"+NNQUJ*UQ63@
MR4%T0R,_+?DE"(:76CRU$B#@#^),]EO:4GI,KPM1<(]OI1C6-GEOH1A KQ&8
MF<+G &S M*UU7*(B.2$#.&>T>*?ZM@LMK@ Z:/Q@I/&0C:4?E&G^A;JAX#OH
M3+J #"S=.8*^QKR)J'4@),ACO<X4,78Q.QC!<9$C>#8VS/CF9%W &P^!5BVU
M [CG:J/^226PNJ:*-SY3@\#?MG,-BA8I7P>J9NB2P84OFGHY3W)TB,8D=)BW
M'K/C8H1:<O^6<;0VO&V?TXEPKQN<N;GWW!LHH.IP9EDDX.WNA1P'W.$;K:2/
M4B(TZDH1E\GVEB3*?$=$P&22,9%)W73JV4%/ -U>2BPN+!LM%^0E>AG<FHBP
M@]Z<T_?0I(YYT5Q[9GL:<4U$N%*%1V>"AI&V1*M$=\C<K.&@":_60+.^FPU/
M5B=YPTZ.36/+D!X0N=*--HVRI3_;??9IUH'1A:8@O<U6/C?C>SL/GF"KC8*X
MWS4#1-,38YYQG055F@[%ZH07 9306$W $A2[Y[!QKT!5 ET32N",!0EFV)&E
MP=Z9OP=A?M7/ J21W61/RXMB:LI5%KYV5;8[N[&_GP7NOKSAL(=O=D.B$8K+
M\OJ3 YL#Y)EQ3]K<A"E&C_E>R6+;D7H#B'[+.6J+P].&LQL\$9000H-ZIJD7
MS&0YNP#O;26U#B$C>R@C3%;)2]3$*SC5GW5/6Y<6+J9>9G67KO7<BX^R#]:;
MZD4?X8.F!CXP<H?@V*M\^98<@+6&G52^/><64WI7QI#,[ =/:<84E?&Z--CS
M8@5U$, CX4^6VX;W3KEB0O\HQB%[6-Z:N:>'I_QC#Y\UK*UB?Z4KQXI=<Q*V
M(&GNA\ZA*B[P%H!8Q0%?E>_=$BDU^:<>.=3[)RYDKH&Z#+[6 (87?@@_(YWT
M/=Q4SGDNN9<7W06Y:J87Q27CEA*]E$QM80BOI498YUER[[[MG$U<%'] /XK2
M[[<=:,X6FXVGYW4ISMWO:)&[U0$ ;,KT)/UWSY7"CR\3WS=@>E/X3.$C9_+$
M#*<EW7O$KI@( ,;;I(S!)ASH"0=8N &XF;:W7G^?O9H"T/37F^P-HEO:+EC-
M@U.L<FE!]$ZOD^L@E*I65#K+)OI.JM>$0,($+W,5NB4XOY':7>YA15CD@"L!
M2BY&<:?$)3PZRN.BNI5."SW2A'Z(G\)N003W:-[:RI)KU<W]&9(HTDT5ZNWD
MQ&/456$09C[FQ!8B?M_&&M:C.+4O;TVR^H0X8N6@!5&PT;_>SO!@1]%S!H^%
MA,4E_-=6FN2TE:EGB8+>N;__9?PALN!/'V_RJY)??;S)K]Z[O65RZ8&&.DQL
M,7%!W73IF6L#BVOC(G6%8X_*&!@H5C)[A[-.8[ZP?-!2>,5UP^TM+!Q*JY9^
MU;>TP%?1<R/K/:(\DA1^/85N^ @*K.T\"G9_=J5'&"*98O=8TW@?7M!CJ%;"
M:#L1EKFW.Q?]S2&H<!&$/"8'U,6YV_1+%OE 23M#(:F51K"H)<K9(<$+;&_I
M4$,1VMHHT.;<9SWUM7;IO5-\U]*^(2&A0%+RN')-T4BRQY@5WL);\65!)IUN
MZ?O'/6!"+RQP@VO@$WI?S76AX2LWO!L;LL5;6@GFMAXRK,0%[<!/.%ZZE>K-
M@] P'*J0@'R^DS"2'A_CQV,TC:J^/D<UU[MX)ZV.=7 P2%4/2)$O]C98&S*P
M(LH\<?MNKG(P/L&%F!,H';"O83(3_<.([NYB7'__=]8P:(H6($]D]N!L!<X%
M(%AUM_[U8>VV*&I+)&:S,QKBWN88"/=8.78_PY-<+ NLW92(1>.,G#N&X8+^
M;S7*/[A(_9_X_#NRI1,WQ[=L9Z)O]A6YWZ;<W_?US*/#O#NH"\,[@DP"VV%T
MZ69R< E!(C,W=I]Z.S!K(^+1@>9XKV'_PQW'.[ZO^&\)&_3JY>#D;'_O8)C]
M[)[ZE?O%B1N!^_5/^Z=[PX.#P>'PZ.TI_F5C(+M#?+[+T/8S%M<2KXG&!2T]
M02*0G1>5XAH+3Y<MC;;]PO6!?^+)/BCY,?.=\)C-IO/RVIV7;0W%$4B2T&EH
M+K)*^:%;+W&CE59ZYE]F)\4+(E6V6XEC1^B )9P6]^ O+R^I?D(6UZBE3JH)
MJ/@\#Q7AM4<%=+9#0)J!&]\2YP:&EFH\_J5Q^:00'Z,,N[))Z0E?2ZD$!=R)
MSV_02D(]J'4N=C:>17KC,+SC32E->$/FGHB)G'U5YG;6NUOCP=<4:'H5E GI
M\%ZH]$ QOJJD1"C\'B/TE/6,XK8@]\UF04N>T^!$X>7_C(0:JBLO? MS9ED8
M82I>!BT "O!.@,2=TKJ"[*7:;>[9T;$ET<B#=ZJZJ0,8GA[^_TR:LBA#CI.1
MX!(+!2DQA"JM6T8ZV9?EPW%Q0WY;*WK'5'=1;\IY7PO(PGM1SJ@J*G0&ZDRP
MD=$O8,'5I--W<D@J7<ZS1?%;:5^+__=X246=\JHBER4EG6GIYK%)QB#>X\38
M9D.G-S3#.88N)@?B'%V"/DSHB:(7]06K>7J8 DO6HB\H=67*O0*VFDN\]%F\
M7X2]D"B";# WXT6I8 F,W4D$BY([5OCLTY_;)="[EF-J"R4V&4," A\)J2!S
M5"+-/.E,0@I19"(6:&&T,4/Q7"8W07$M'IR794.5(KG"V,]A>L8^IZ6Z)EGZ
M9),LE63IDTVR]+YMVS-1^$*- [1HSL(9PDXZJ%K?713H?+9,(P5G3!6D-!I#
M$DK][2K<XMU[VSD@-(8:)8.REG0_7+@;$&Y'99PE)586#1 &@$=+RA**:*@G
MA&5@XL5<)51%%C)Z&*A!^1/\JBHRT*J!] ,*:A#@@6GEX ^0?L'2>BS*@4;8
MS7V!32NP(MM8E ,NA#B0BLI8SU\\?93-=R]WLP?PCG^IFU^S/90_<D^R@PWV
MB".46($(F,FQ^FT11!$1KN..9B'SDX ].7<S"T@<,"X$,L2DS<'C *58L1#0
M53A/VUNIB9K=9.%,C78$\5$#GN0)AF"S\2U#,#>!\)R$?YA@7@O<N[>[I[L9
MQ5@ SH-NF%%],4/Z/RB1SS#, O:N"E9ZV5SQ;(.(!U$_CQ;+8JH":E*OEXCL
M^GU]&;PI*Z%*6PJW!;D@_!:VMR;2W2\[EVA&@DWK^SP^_)U]3D?O?5I2J3I)
MNW;[/60+L1%8L?RK\/*<04' _3AGN#W\Y'N^F<7MDI#EH@L-6TAR%Q23X/7@
M-<+7*R))]9B=F6\ISU-QBI7210=.H"!C,%H (EIDSQ_M/OX2U<;!)^ :=53]
M.6[*AV^6.%1)@4HS*J\T 2@!JFK45%3;'S!GOS\E'D M7RVE2;_DG;&':/P=
M5(3M8):HIR%7#MMYP$>'VXX59JTJ#^XI>COF/2*G.]#"QMIGU23LWL^C!HI&
M6BL =@_T @CCP;8"EDT<P](!\$?EGH^:-XWHA;L @?J#KI$=P12%6M3=>_!%
MR_$MKBGRB=BP8=+DN*2E063"_=630G7I.SKL/&DFE4WU.+R<YT@/MH77]T1/
M *.,<P*M(%$-HL!I#/RBN5<4V]3#T;5*TZ$#37Q*FJC7CG9[2R S6JK@2>!*
M8\"5;9-MF@;PA<N X)AJBBZ:;_ ]50T'CYY53E<D?IM]-J6I"#@C^.EP5787
M@A?"XTRK7W<%-PUKTI#S$";)&B-3N)<9W#--5EU"I@=@-?W72.5D%2V$\\W%
MI56"Z_' 8;$8N-(@X-)0BM5DS<6T7()A]U32%47A1+/?%>;Q>A06CH5XJTU%
M=MT!R@79'XE^76(1\&W>\Z^$CQ11Q]2IYOR?BJ!4,UC+XQH]2*/M4."NZ^D*
M235:([7:);>S*ZN&DD$922?:_9O7F7Z=WP@UT@CRIG7#R?!!"XZ)EMC3MC[8
M9]A1-T-..N9'*&?EI%I$N3!)<%7H_O(])8_,@6A!-X\8Z<#SPK@#_QJO$R&E
M)^-5-SV5*DO5W&NG(I-!W21@')Q3=GY#>;!F)V[GA_'QV(3'9:JL[CRN).ET
MW.1I0@ICMVA.W&7=0#AQWD:YXMBYH2(3?[@L!:\:BA' >W2NW+BKK[.0+@/W
M;0AF[(W.;[@#-)).ZZV)(&^+D"+"YQBO:?+:#-G<;-3D1OU64D!8U&W&#XF?
M^17NLA'U.OA4=]Q^H'L67RI\G]V<<_U^'YDW%7:-=E$ 7$(,C)S"3W<?YQ]P
M">-%!!=YHA5@PQS>Z:;Q#2AHH$S&/]G9VV..),^C5LETAZPS4-)%#%8IN@T<
M1.1PHED(FK YNX_$'QB_0!TJ-TXM60(EA'#1OS;SAC5(2V).3Q"X1-]^3H?>
MFOS[TTW^7?+O3S?Y]_LVODS'_@-E#('_Y:"X9@)V9U<1_R^->"/ZB$;X4GW.
MLRMWJS'R*MG$!3E.;LTXDQG2%Z>/4C7E%S@:*4H32[&0#F O-1N7'KP:WA,Q
MB:9%XG3!N51);WMD,4%CO68J0 ?F3.,J@B,$8' 7E!HF]TE+[L8WL:+*&((A
M64 ;(X=H^L)I:;OS)L(J]>UD #N11<!-G-('O'Y/I>&..A$_DI'R6K3V["B\
M%N+VUBU42;WVJ^J2>BE2:3UL#54(M]=3AG&Z;-U-IS>27"'A)GA"4>I#&4TW
M*:T[P9A] L]3QKS*ZP[>%_?_5<[[NZI'J$O2+L\O*X]QT5N[[=-4[;@:V?7;
M-XJ,!Z%-GO$H\NQ533R][I<_%;/WD-R>Z1E;C%$N,. X@93)DI%8#$J+1*@R
MD: BP4"6 5Q8='NP8OCI:\S]C99MZY4V#+U+RFE.I"57[6B6K^W.-JBH0#]Z
M;EO N4L6N@B;A62A!B-)?/G=E <H>&KU9F>%%&,QE]2&4LCQ:Y0$%NI#-8%\
M6NJ>Z'E=0NZ*7P#X2  RDA0 =)?.&,-&$8Y^=]W2H[G8WI+!^V+-1& _:@4%
MAR6_)YY!EL"P"E?)AX 8KV!*ZZ#K#NMLQ -+:*":VCZ(3!#+;!!Y:EE)83TH
M?APTE,F?=A1LR39RP4N<JG7:BX\S)K4BI#$PP:3U?6.V +RV3)6J?4C>Y:*N
MQXPS4;F.GGD5P*48]L,ZXCO@W2%YZ$2NQG#D!*QS)#@B-ZLL9SSG5P,I2]"-
M$1DY"ZL3DPAK;N!U;LR;A:0N;<[0)U\=O6),@U3? 7%>#&6-0A1Z/:9OFY7$
MW7EVQ:M+,'@KUJ)!W%>7YZ QI*@UYTP_[%QLHD=1K^CF]I;B#@4K$(LU>[B@
M<1>,I!%D&A0:F+$P06NX77H?Z',*2>X5Q_U($G%N\SE'T>15UP33/3I0+5ZH
M#'#0JI)NX(:+H&%N\WIZ7L]C[4,:^=[$/GP]LRU1T]%U3;QL32FM;K!3X5"G
M]"!5;Z]%_F'F\8C&UR-2-JS)EOH:D;!-P8"4N)7OC(!*UZ-P\/+V]@;71R5H
M94GC<PB]:\&7"/N: 9FC? >=JPQ A*/$DS5)@F7F]CTU E+65GGF="S.EC-&
MZ*I4W3HXH!7A$&!=8)Q>T0 .W5QA3Y@B"3[ V5(I\47$?.9"_FZDA!'P5B&*
M1)S8X>G^#X<DDSK)GCQZ],BYZKL7N_GU]?4N0"+A2KON(CMRX*.K6U 5GO*]
MB0QVWA%K4'^"D-R1BH,\$1]]0%8'912,,?'M27;>=(!:WKX; 72[CV"#%C!T
MUZBV@_QBY#?85R"K>L?/"[Y*.4_'2F_>*GHI1*F0C"_(.7*/V2[RE_*Q89;<
M3:(2U'WOZR>G8JZG/#$O$\[0"R_AQO3UF#[NE#A%@C,276'KQSX8]+'D82F>
MR5*P$D^,2FDX3049V"FU(5%T2.F$RWF)>R6(1ZA:X1P1>)?._DSIW6YO7=45
M8FZ6,_;NP.^13#10DG&Y=^';]+SK9UG8J 58!VQA5\'A2E<%\PZ2Z[0#R/XJ
MP[^8X@I:E8064DK>.0,&""K$3U2HW%0B04T76VJ#)_JZS8@  <;98YDL!&!,
MJAFG@DAP%C!%4TSZX)E //T02X[>5R6["KBC,3C3_O;IC?\+]](7'%S$*19M
M:[++@<AH$NO!&7Y> <0SM*CF2[H4F0+@#U40G>2#9C;#H 2D3 7@8HMZZ983
M'FYZ"OMU0-3-'[0")/T5'ASBXC))#[Y<> Q"=>K0.VLU2R[5/[SA<TWR_=DF
M^2[)]V>;Y/N]'T!/50QU1.<ZJ^:YG3ENBFOGDJ$LCN W>W@9H[8\$S=!1L]V
MKVJK/'FAI)(;Y IVV B0.[4B@XP2"C,X.2.R"=]_7E >)"<GAOOK+@MB>:X)
M;4FYA")YCPYR*1O7DB=DX3'JT..\ %E8F[B Y^9,K#2J+_BX$T !I4!B4 *S
MJXPJ&NPUOQ 4I\"[N6U=8OK4G6$P9F0U)!Y#(LTB[$BZIS=@]@->O"LX0N@S
M=HYDWDADIB;U%QB[.QR\)IN+H3%K7 H)* ,0+>$OH31N+5?1@:PVND(9PELJ
M;07^G0&VY)D8)JLD$:6'D+O)6S:<M$RK6T0D*P0YI!>#!8*@G1'SW DY2[Y-
MI_E;#MOBX@)J0 L#<21A%Z$JMVM0$[RMAQK335R@V'#/<S_UGJ8&BQ$!"^VU
M+$--S_>%LL'VDP:J8)!5$8R$JI5+,G>$#ZG!F\ZG&WG)JV335]UGK9^)M3;S
M&T MR4YS[&!G7+E/"/OIYS]JB74NXZ4+&:?D,$_K%H+GA=OX++7N+E'?L,T*
M>X^=81(5.5+^Y) "?HGG@$H644[\G/+D%9'94;<E&*P1K*,I<_5)<>!!9 ]X
MC,!JPN)3[F0IEWAL="Z/%T$ZO"*;N7?2.R^D]H.,"\P^1WTI@%N3^H+G[G->
M^Z)J)\4(]26C/8IR.;"TW112DGNRT!E<LHM^YDW5C*H0:P;(AQ5>>%0U[I""
MLQC*%@:?/I<2@$8N<(0!K(ER$Y22-MF:D5MS;IDBZZ S_3,7A.Y $:P>$=V_
MSU/'^E!FHV\2G>NW[W/9OI?EN-)>P_VP]$%YO]+H%GFL/(3'A'8,6@F1K$?E
M'*B*8ZETH2]+,C^L/L3,"0G"HUC%'LDS(B4E5OD:!00%7HPVS;R#RUVAJI"F
MX!#/O9T%K#X>&K@^0-6/D.1B[ YKV >8MYBUA3$8-[BY OH%6O-27646#_<O
MZY(%SFD_%L37C5DL$^&C!0(0F'^MKU:,!W1JBFS;@F6/P[H!P2TH19NQL!2T
M&Q77%'EC-ZC,QV:/]>PQQM ?DR#P]M9IN<@&D.%G *> *Q::#[>+G>G>O9YP
M(S^VBB56WRW6B$A&$&C437<(IR9:(Z,(QZ[',2\49L'$J53 [HZ'$1MSJO]Y
MLN4 (M%D5C50JKH8TQ /0E.:IB!$N9B$690GFC3%$L@'>"#N4"W!T:T@^8(R
M@S#/N9@;9G9'696+NF%"9AA%XWUPZ69RU\)&.?@V^KQ!V4']PT[XDBU U[FD
MNY:BU!/C/27(FZ%IO!T3RGDQ^[59SA<C-J>$N'$7EUH%_G9$H0)<M6:=1 P[
MR 6""1ZQEX)!WB)8?D$7DW7>P_)WQI1#Z@U)BA]?%V-Q:1K))0'$A(EVKK!C
MC_$;*&T^#M.KZ0+#]I:LNO?%V',\(6VV1"#16G.+H)Y,]/,L#3G^G(S5FG3=
M\TVZ3M)USS?INGL_W;BE:-_]>E[BW[:W#JD(&'2L<K">'1F_!S8Y:5S[7H8(
M8Q-UYWBKF4Z.P=E!TCR4*%-E'J/+TVV5C-H<<W:GTIF:=@[U>5(B5H"3@!4#
MUZHAT([_E3:LK1_#FB?M!V1Q[+D:ZYJ34SVKA12>L @Q/:#W)SSR=2&T2 G<
MEX&:11T?1<L@6J;*1<5:">BH;%3PBP)8@/0*ZT/\BDG'";G\-QA@:Q$<\#)+
M)J%7]\G>NPE>U1I!MBY]4^0;JYNS1I.E-^@(M:32PK"5WTZ #'4>U4(*C0)I
M,P[:&F;HA>D5;BJB2UNFVB_!PUEJTTQG^82$T !DCV1QO5C )'1YO" )^@3P
MHDDLKYA9OEQ%R.$J]+ X32]R]1Z !.$D N<C^@(*GZ+7@*38US.O6$(H=*;9
MRSAQ#0Z),XQ64W =,!\U#Z&S&J([VL3CRVI6M8N&ZJW=/MA$;W($(Y=A84%S
M!/B,&6TK(0HQ@'X5QGF/V&GRT,*GDU Z[ XC,WN;3_K2@LZJA3?;+0:[<S8U
MDE0M#2AY;QDZO#1,Y].:5^T+MZ LWT4 /R$!,;A?.D860VRF7ZUNH!V)*Y9\
M8E#%*D*>)%9YH(&-G0VHE7DS?GBI:WOF2(.04GRN@*4(=&75,&WDWVE9J&86
MBI4\\ZI^6M7"GFE0G9D29:3D,OK)6,W\LT@T=1SXJ:/OXEU<N'$13\IGY%_?
MJ[O$C9T'E5MK8V*E?4U)IH[^09*&=^&SJ9BX@JA/KZ7Y*H5*%4S<0O1)R7R8
ML>HD%65(/ (T66>A>-NO%,,L:HCHE1E&S2M&Z3')/,SM+8]3Q"_'LGLP DAO
M^W/>9*(QVL.,;ZAX2)!+1=W?<LJ<0P+B]DL*1=V<DPJ-%SDC>F$L#7Q>\>2]
MKO?O$$P&\<"XN('KN34(/VQO_0A1)?ZN7(QV8?5#E0A/,6 S @=B/@>/$%^2
M=[&=JVH(7PM%G5,68UXU0:<0E1:M:9>D=-B_(,G=[-72.4C0F( T9;X.SC<2
M3FWTE\4MH9MX.#!FMY11"<G@L+N8O!E[A\VZZ>%K9H#\GFFI-"#Y1,[>% ]0
M2O$K6A)ACW?@8)'7QWDH2! !5'4./#S+646<0/ 1UGA(NAL81N5:SF,4X@S"
MO6G6+*<EMTMZ4F))MQEY$:*D.J\NELQ-TTBETHV\GF*FC!L1,2W?%).%;P'A
M2B>O7^XBU$+"A[2:LLNN?#Q*@8N0;7'3V8_%2 0K.)QS1:@%[J:&D0(JKI#"
M,%3*"=CU:#0BLD"',:P7_/,$_3/D%:)VP[JYAE[5EL 1\ZGSJIU]H7^.*RR3
MCMN<_^Z<Z7.F8;<GD !_@J#.GWE^X/C*,(UH2!V%DW COG>KS8WM%:]>NOW]
M;K#_\_!D>^OH3?9?;T]^R<Y.]@<'Y E!4NDP&QS^D@WVSO:/#MUMW^Z?Y=G1
M279\<K0W'+[>/_PAXX^X+^^?OM['#V:O3H[>_O#C6?;J%_S;\>#DS/WTPV#_
M\/0,?W-T]N/PA'[OGNG'(?ZX/SQU8>5@[\?L[X='[]RU#^#KK]T=SH:'<-W!
MP0%\_ B_\</)<' V=-<;_@/^G!T/3W[:/SL;OL:['A\?[.\-7AT,LX/!NSQS
M=QO"KU^='AV\/1O"9=X>[AT=OM[WU]T_.1G^? 1?^F5["^X[_,?QR?#TU(T"
M)^DT>W/D/N'&C7,$MX$9<_/D9NL/DLQXI6OID]V>DL;N7OLO'YQJ>\$QNFQO
MD!=TYV]?[=_#W>5)]V^;E_]ZDY>7O/S7F[S\_>W,W>>P-YU=?+=_=N@,2/8.
MS,_1F]QBZ(DFT9VKE&J"-(@GE!'DE83S(7L59'R7TQL/N*=L9^AH%<O%^[I!
MWEUJ"JH;5D'E,Q5/3%2I!O@H]O>#GP,BNW=W;'9>P!G:9) :.CT>[#D;_Y]?
M//H"_WT\>/U:_OW!-[VNQHOW\-%'7^J&A;1),6_=RI6?OL %][>S$[G!%8"J
M1L547JA;U5_(HCQ[G>T=P2@/__.+IR2=M.=.COW3['!X]N[HY.^G[L@XW",9
MI:_.7OOOZ3/;7]IG>MBZ]T(/!HJI-_5R\?"BJ<8/+^NQ^_VT B<!6'.Y*QW\
M+>(B?T%GC;NP^\_)[WB<U!#O:-P?-[J7KVY>1'?6\3[1%;'>%G^Z!QL^_*FH
MIB\^=O;Y4[Q2GWV9'FKTL>?N8VC,5W[JZ6.]VMW^=^5='S]:\PRWG%G=O<^C
M"W[$(DJ^_3,HZKRXQ9*XFW62?(*OT/")U](]'>_NI%KC/KQ#)A:FV:B!<:<B
MI#>G8$P%D>#K.R^R3O/2G_Q<%J?QOT^&/[F8X[5SV5UX<SSX81C&$MG!\(T+
M4@X&AW__Q".!%N;!V=N3(8WB#810;T_V?AR<NK&].3HX.'IW^C^?> P?U(+V
MS<9W%M_YFW]-W_DVB^A3[5N_-\*-<PK!?S?#0JRI=>.F<#F?EPUT!'SQLFB!
M4!=S+-M;I\.]MR?[D&+0C9<-?C@9#G]RYN#N=MZ?,>"@8BB23G!YYP^--C(-
M-K:W[CC:2$[6_;P2<M,"P-6+['\_\G]_C0GYV_Y+GR]R$S/P:^24U\A-,&&0
MVGFQO?6O,C^R8%+S\G%KYZ\Q+^BNW^W$_$5F9H@L+)(5N*,9^LRFYHM$5@2.
M*6]V_[R'>3CVUX9[)Q0@-5SXU83(G)!ZJ@WUK"0^^S,_<$+$Z$7V[Y]N$7Z*
M1\#Z:6);_9D'G9"9ZCR!)[.?9D?7C MV,5H]^A6ZDO[CW[[[YMFS[[-GN]]]
M]R74IN47W\$O_LP/S^7BG@=?^=CRD$ @^;D]]M!% (=+8#/N/0/^O,/OB03C
M^&_/A7/[AV^'GRI9<L\G^KTD_=)3^_3;3QX R/5-CN)D.2T?2IZB+Y_4^QRF
MS/-%\&W.,^&W.TFF[S.;N[6Y%,BC\']M'B48)"7+[F"6Z+\0JW] 4*]S^-6K
MH]>_O(0??CS[Z>#E_P-02P,$%     @ <(&H5M2?T@G45@  *A0" !H   !E
M83$W.#$S,F5X,3 M,E]A8W1E;&ES+FAT;>U]>W/3V+;G_Z[R=] PU:?B*9.&
M\.ANX# 5('2GA@Y<$F[/J:FI*=F6$S6RY"/)";F??M9K[[VVM"6;D(0 .74O
M#;:L_5I[O==O/?OCZ,\WSX>#9W_L[;Z"_T;XOV='^T=O]IX_^YG_"]_^+%\_
M>_'VU;^BPZ-_O=G[YYUYD==/HOOWEG5TE"Z2*CI(SJ+WQ2+.Q_S!.#I,RG1^
M!WX(/WWG_VY29+,-?OPT6L3E<9H_B?#1>T^C.OE4WXVS]!@^*M/CD_K.\[U/
M)^DDK>%MVSO/?GYW9<--D[Q.RCO/_Y%/JN73ZQCI_=[O^X='[W>/]M\>1._W
M?__CZ##:_?W]WMZ?>P='71/X[+'7K>@+%_/WJJK3^;E\F.:S!%]Z;_M1FM]Y
M?G225M'[Y#BMZC*NTR*/WN.A5M'N<9DD"WAT.-BJ\:%_9+-_KXJGSSX\MU\]
M^_G#\W^4]/$H@D<6\2R)XGP6T?8ELRC-ZR**JZB81W_&Y]'#<;1S;^?!.)HD
M]5F2Y-'NM$ZR%)=5GQ7E1UC.?C[='D=Q]"K)XK.X3*)I42X+GAK-)%$3>5DL
MEG%^KJ<QYO'CZ0D.BH]7R6E2QEFT7)73D[A*RBJJ8%_BNBC/HQ.8)DQQBWY0
MK> /^QC.P@WUSGRL!AL.8*PQS##+DFF=GB;9^3CR9VA_5NE);E_M27]U>K($
M8HD"=K5:Q4A,L-NX18?)=%6F=0IS,'OD?C:.9G$-Y,.4@X_CO^FPBKFC'OQ"
M2,"=NMWQ:"M\%%&0?+_K(^G;IN$ MW4"7^&VX);/@9Z+L^K)-[8C_"<NN6.\
M^]L@6C\\?Y7,TSQ%?D)W\CL^^&<OGK^,EVD-S_X7W"9@R8LJ6E7)C!A7E!=U
M5, =*<]2N!4SW!9X"JDAQ;L5UQ'R7_-YRO>M?8NBZB3.LN@D/DWHB442YVE^
M7$7'P!%S9JH\=.<KX Q>P.[L\NSX.<U&F*LR7<*KY76-<=W79@:71\%K:>MZ
M:3E\W$I ST[3:>))JO A@7"L8>/*^@0W_1"E&&@ C[>FE\@/O[&]VYO/69CG
M254-!Z] \*B-I(V#@<]2V+(RJ9;P;"0B;1^Y"B@:GC9U6,,+Z)J4R;]7*2I%
M\/@$R#7-Y+:M8"HED_C#1\\./[Q[7I\\^QG_&TWC+,EG,3#I&:A/Z@+X(C':
M*N %<KU W8'1X$.KOLQ7</1E<IHF9V89P.]%>B[2JH*)\OB_=(P?><.#$/?'
M'Y%<:>X)R9O9C%AMY[94T=E)"AQB 0/ KMA-,@H#OLC0Y0[09524YM_#P0/X
MH'_CHHY]@[?QN'&^?HZHQ?2?'FBFUWH";B'$7MT*AH.++F'T%(7CLBQ.TUDR
M0Y(?XP<GQ1GJS_QO$@K>(K4*!D. 2$GG*0J8UO+XQT6>X DN"I LHMK%DP*8
M4B=UI+!S**F(.' #8=+P!AHLRHK\&#2]:C7Y6XANOBI1I,FS+.BF, E\&>^P
M=\$CO-^H],!/:2L[MH_9YT0D33H'2C\JXQD>Q:LU% :?# =JCZK";E.4SGE4
M^L6R3*;)#/B<>4>EQ+,]/-JN<60.:FQ6/+8O"RQP#K.'M\&5B8F0^"#IO(!(
MU4IHB_*N??)V(0<VB@-.DX1^K=YR;<*C@YG?9('R#D8H9EJD?(YHWMF*KT\T
M?Q.[>^H;<I^GZ>QLS6ZWL[6=;:WG=D\_>PYV]/]V]V[T.DVRV9/H77R</(4A
M_KU*\FD",XGNWA6G[[-7^_]IILF#WZV+)3RRLZS-=.Y.BKHN%D^BQ_C9I"A!
M;-O/7F3Q]&-T?_L1S+4JLG0&4[ +;_LV[3MIE'N!0> SO9//?H89!B8[*9/X
MX]U) G0 *UK2"O6K'P=>C8O2TU.[W3FDVL:?<1]YZWYD"G.W]G6:D5I^!<9*
MPT#9N7<A R$B1^G7-!"2N,S2I*I!<8KA2YAW6TW3FNPR*1=IC4Y(T&0/]UY&
MOZ_260RWEI1,4)V;FG?W3F;HR[2.3_/8)--.T%N&J<CYCR*;-1SM<*C-[ZL6
MI=/^GM"72 7\-YABS-],T>?$9 1:<UDLHAJ60!<"_PM4>GLV:\]F'[Y8Y&+D
MO8O+^ORB>L*CZ_0R?4M;>TX<]'9O+W=O2=QUN4?"K"3MEY'L0-%RR/=:WQZ
M.H W154EU84-M4>W=J^_G^^R. >1!3H?DF8Z6>$VW7H5+FMWRX*TU)5/L8XU
M+.T#L(_3;#7CL%7<Q2NV^"DX 5:#BU4=92EHF/0@IAJH-XJ;E5Y;D9:<YG!F
M"W[I$EV;Q:K*SD$M$AV5M!GO'<R<0/-9@APA7W0>)<83!4JIFF7EG,0YJJLI
MJ;FK)>:"K$ 3>OC@WBZ^>K'*CF/1B'W?[G#@<T$OO+\[K4>D@\4PQHR]M]5J
MN<QH3'X=KE%-WGT=-EXX_B?^XP)652)IXVV@%P%YX[KD^[!2%TV+4TI1P=$[
M3HUS2? :D1^6%\ V"7[A9EF9B3FZ&0\']LAA1E5]U^V^>X\; 0X75@'"!GXE
M&2\\N3*!Y:&[ /=MAI+%./"[GTPE[.JF<WN[U>U6%#$<.)((6,Z<@()$Q<;B
M'$X B2_-Y=X"XZ3C.SR)2YSMUH3__5=<EG@=^'-VJL-=6>&=A!/'OQ)!TBU+
M/B7E-*U@,D*R\FM\WW34-),K?B4\BA>0Z+68?@R^'>A@6N2Y<'FZ29P$4J=W
M9VFV$GY2G*9XBTV ?CAPX^/KMF8\A\I='AD,*-*NS"V'GJ4Y5<LLQ62>%$,5
M.3W/-VFFA-88"'=JTA3X!B*' .:88>"3XTPA+H >I^,"[I<7N1I'[9 5S4A'
M=QJ\@&7E-$$#D>]6^,'A8 LW1+L*^*<V0.4B;(LXS>O8!,N\6 J3U!B729Z$
M."\X@M,A/*P/QML&<K)@]MH(=P+#2A@-0Y(EHNQZ66@GJS@CXN[;(]!L9\D4
MC@26YUC9Y)Q]/2K.QS-M"P'AF=TCD*XRP<0N( ]@F4A@<R-LV.8G&3L%ML>N
M&%H+O=+.J$O#YZNYV?!.PJ(G=18:E 3C_8</Z1#QDM*;*T4IDV1:+.#D@3.E
M.!*>$6P[[K11 $Z+;+7@>&@,M[2\6\SOT@/P'%P/NK65#:WC+^#U)1[B<C7)
MTJFO%B@);&8'Q !JMM;XXNBL1)4![M@2S!OX79; /TL;_^2-'"/#@5E4>)]F
ML :6E22LIM-D6=/F"?4< :^H0/2 Y8-S,S<DIC?!K\1=@Y<'^,2"HZ1QW=PR
M?GN;S[3Y)*9<YC"C2GA%\FEZ$N?'1,+DS*-308W#L1YZ 7\)6](8^0Q6IWA:
M+/_"D<?\)4PW%S_129)9G65W#A<X%=&@V ))CA+X"7#L"9"1D1J>\D0/#@<T
M,]HPRMK!-TV+55XEF=E@>?96AF\45-EY&KU=TM5Y@E,1&^=I])]QML*OKROF
MLOF^7#@ZH[?!;,#3Z.A\">O<!0:73I]&!Z!M\B8=%+CT'2^28GZ%W]Q&>6XB
MR;?55@YM]/BND#-U6'C].4 =095X9'FSTD-+;SJ5B]< <X:_+C-CEW1$9R(.
MSC@K"6QDSDU&1_VH:4^ML;Z,BC<<=*P<!M9O4\99F=RE-_99::#C)5SE0LH\
MJEUK;#=*@;J@\6;UU?!:;@6!OA7DHKC_*."H,5_U.R^B?M\%B7+6&_%U$H94
MOHP4&380D?7#Z*C2F$)7=)YLT$0EOH5TP>-5Q@>+]!3/40N+9\4R/$G03LE]
MMYH &>3HEL[.17=?4'D%*LR<WD\4[,WZEF!:!+/SL)-@=A[>$LPMP3B".4PR
M3J\@1XO$E_]C!38:[',>@SB]J-_]P:W?O;'5*M$B<#^W4O9$L?F;G=^-3V.X
M(V@@6K,60_\@BH]-NH8SS,S-@/LPG[.)".]RR<&B&[%*01?NWWC(5?L5I.[,
MY^P=2]-1@ M\:V5%:ZLT=KAZZA#,W[GO9/D6JZ@N1*=P6Y^]?GMPI,>^.X^!
M39\_63<Z/5NE_Y7P9.\\CR*LZ\;7/7]+9+LLTX+\,*0#<TH7I5V/ PY'$!]+
M=%,@!9(/D;Q2#4+O] %2[,-DJ[-3BGS/%.KHC9K8LC#T>)+OEU54<@^1[U<Y
M![OBYG3S7-R&%6(J$^4,=30@TGQ5K*IH$E>8C-7T;8%2MQWMQ=WY^DW#QF:N
MPU.OBW(1'=Y]$&TEG]"7A8GS[3H&\FOFSG\'0YNE:E]>SUZIH:@TA//,* LI
MH-RK"8H_.(J7H(< 6<"BA@/T]#4\D;@\//>Q+H"0Z*1QZ<-Q.OLK&;$E)_[N
M@AW46ZL\([>TJP4$-C@UH;DZRI*XJJ-?'_T$XV-8"T^[J@VEB'MO%% U6N'J
MJ"M:'=<UG*8<&=>,8QU;GB>?HEU\4&P^-0([GEMB.E)2VI/+L@M]([W 'VQ:
M!Y,7LG23R= ( , _\WC!05A8O$R4R!&%55*:F1GG+A$%O_(?985?56!T+M$-
M*\S!"#DXN0KMP.C0.W?8$1<8;==/^AQD!>>,UNP$CQ+N+.@F9$A/8_RFDW7P
MQ3(^?J_66\6XAX-0D)M_I<W_D6Q4(++0'4:H2#U?UD!D^/<"F!W>/%:(N3XG
M$^9&]>)@B:]J8U9S. E+AV)^/!;GZW()*@5=X7;ARUC=FJY]^Y@DR]X2(L?5
MD'8W6.@*GL]<01&SWBS;(*#=-PW4H6RH T@7Z&W,6\43*<I@*($#':CKB$%#
MD9'/BV2$0Q0NO,$W6JEAQ&@UZ1K?"6IM2TE4L)*O)SBBW\G+=.N*J[9[?C@(
MN^"])7Q^+.5B 93A0%AL$]' )]168=%H.SIJ7?LZR9+E29%C!G1V;G3<0("R
M@WY /M/WCY[<NQ<MMQ?;T1;J//\JRH_1R[0^)R-V1%+,JPB+/K"0H8W11Y-J
MP6,4^\@I]IY+$LR#]PGF=V!^19NGI:#*SU!<PANHQD['#JOH-(VCY.X"WFQD
MU\;+CB1&0\:SKOS#6^E/I;'#<.WG*7)E?ZR OC86#<&KLJ.K+Z>$_@(,=S4G
MW;KNRCL<H($Q$OEO3Q[<B^*^\Q/*M"MU_-7Q+I,5T<-PX* XR UL&=W&S@D;
MUEE5G2I,TWADMJ/7<&RKDNZ,J:#T(L/X,F ,6&"Z=7_DS5PF.!QPW>4T-NE!
MC9T$Q<X-TC5I LA Y2^=N9,2UR[($BJ@:DBZ:ZV(NG[+<).@W(/;^)O$WQ[<
MQM]N -5V&/B3JS'PHX.B1OZ$QLO,V=V*718@]XYC5I,Z4W3'RE(U_))%:>5K
M24939"GGO#5-C1%TM8+]U3%J:JO,&G6B#AM&:8SN,1LYUN)7AC"]!(RL LO!
MSE56)FH"%?P-?0SA>)9OGA .$:G45LWG17JH7D:FUZ[ S*KFY-(KIZEH.)*%
MD1AMG4JQF+V[D.)F97$-Z=24WYY?91%_2A>K192O%A/4J[O*BX8#5VO&^JW:
MX, @VH-!J;2X*>0OH$URFM-G>RQ(MPL=XF<X&)ZV$LS$&FM,N^7AH-F3H87Y
M.1N--AL%L]F6\?E" #BR]-_H!\:MG<4+X&?5IM8]&=R&4CB0@N5^AF!"%C4Z
M;_@:\TFNR),"'^!DE*48STZ+*:XXI/\8B\>/KF_DFPNDJ9%5J7SJ.NX=LM!?
M.K,*+]2KM)IF184:T;X)6LF,'M_?V;[WVX_A]IU>C51H"@6D)+X6EN#;KASC
M!_M[4X+OR.F8C3!#O25.)"CB%;R"/*I$(,6*6HR-L(Z_13WL#84#\+^XK-/I
M"H.=W7PW*%RV!,>L(5QC'YB&0,76WL16(FOH*D;F)L(^17 FY$12!0?A+1BA
M[ZO+QXJ>87P,9H[N5F/M"R@-RK/P2\>;[7YHS_O\0P2X,R%9/5M-V7WYE1 !
MCW9?O-F+7NZ]>?-N]]6K_8/?_WGGWAWZ]^&[W9?FWW_MOSKZXY]W[M^[]].=
MBTYKG9Y_]-Z\&:0$58^;N<,/$5_WV=$K\\19.JM/D'G\(BF+1Z^>A[[>H:_C
M[>8#P9UYG9954.CP*5$6+%[-G.",_"1:FW#$94K,8LCQ&2:9ISRCGX_>XQ]X
M!I?*?'_9V ;X$<Y_LMGY'Q+OZR& CMM?)A@_L'564C'2J$[9(FT_F5'-DBN5
MYR1M3&(/_\PB,AC6,C8"R2CGI/N#,(N R\02RX,_F0E1(5=1@[+M>-@J=V\C
MT*S L";_6H5+*E [@?E?$=W>$JLAUNEFQ'ITDI9?3JMRW"CAWY7)W=<KRI\R
MI4GKB7;-[R^?>H<#3;[KQ@^2\?97)>$K]_'LM_ 1IZMZ@CX\!S,3\NLCDJSV
M]=J8='V"F,5;#SQ_;S-:BEY?-&BH/,I%B^)L*OETE08 ] .P8!*#ZE.S)WV_
M"_F0S,)J$P="AXUF2]G\6T.ZF'@UL*+(CSAVY7V,FR%27,)9,$D0L[&UJF\,
MXV;8BQ-3C"*<XVS0J>[9GJ!<(\[ZV,-X##M\JDMP8F#V8D<A)S,!JMO!-)6P
MOTKN</]YZ;KE']R#__#6@R\>_(>W'OP;0+4=OIK9U?AJ]N=/*'-B$Q;/L*J<
M*%/XJ7UHS:O,/GBEGWJ&/^J6(RJL:[UW,<H#&U-07O&H6*)?8I534+<00-Q(
MX>%Z,>V&9UMG*!M(>#\7@[RT%1$_SV96QF>5SK]I>"N;G#7H0'4U,I2C@AM9
MP2\K0LLE3]@TXP2ERD8W_ T=C5RJBK>U(%%ZQ2;%0#@;@C(4I],D2Y379R.1
MSHE/$B]Y?/\+"PDDICU']6?K44/)T9TQFBXOT(D=&#.B@U,HA&H/C+-)L@W0
M[8TDR_AXY2@P2U>LV^<RDA)XR4XQ4,T:P$T_UHG8; X/3L_>FG#.03=J1^>Q
M8W(IEGL%BKSH8FBXY6I9Y)YS#G/C)%><DU7;.T7X*1R+Z$^*8#)!NP7TTZW[
M]T8>D&*E<BT0$SI=UEP5+*-/Z"A%K>4*DJX3<^O3 .!TF2ES<6Z4KXZC[4K/
MDV,Z[0$:,&H7[IV.$P;C&)[Z)APT"#?07*I\$@"KED'6<&M<!J[";+C.S%M/
M:;WY?@@G44FVLXE#,B=&; @O'U MD4T1V*7.L*T&'.I+O#$,VP@%3-MV%(X[
M['GF5W6*?4+H)^\T&!%Q?PJ%H7D.Q]>#HC"F]9+JSZF5EKXQ916L/5RB3^O>
M\_A_Q\= .K+U"+6>T#L>C?QN"%6TQ>E2>9+,#%OI'&44S5:E";+<W[F[@,T_
MP?6GQ0RC"&*'F_P?F!/J:_#)),%?476FY/5ZZ;P!!.HQ@\[/.9$2JZR(5[/<
M,C4L,[H\8\?!#3J!0+BSA3R%;140%O4Z]S8GY0+OF!,:1D-LF"4CQ_^$R.WH
M]^A]OQY O3W(N+K>SGPF\/K3SMG;]Q-(2H (U'ALI=D$WK$>OW& 1,9QU3R^
MJ(&<RR>34]J^*7DV5<9LII;<)4W?+_0HD=;B)=/R7U1Z<1:?89&?U#JKX^96
M!#DIC?0=$2F:\'F. !P5A[["OS.:I,YCIF\=0(T#. &R(GU$D#!P^T<JW;CU
M#E2[5NPB:U>BQ.>V:,6X9V#3%L6*=:-I7)V,#1 9,N)VB-*U(Z(XWS+)XZP^
M'T<@KF*;@0N:U&S%@G5G^]Y/$:A5=4H>0",#'.,X!,UT6J:$ A'M\E26F+#G
M^]N:^M=P$&A-%.W/PPH%+IQ2@CO7U<:&-&HU*G78$D2T &Q1ERO)K_"3812F
MZ99?",>WM1B<!H/5#:C&"O.\_^M/>$.0?E8+U )Y\1B(3$J;GR)'95I":)F
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MEBQ/,"'4"\:9<:0"\+-WCHOD&O S0 BBDJ;HRXS),9]*7K%E.&BA5U0%)L+
M/FJKC]J,06)M;'N_$TT#5%D&\FG33"AM")UZJ\7"E_@42Q1COA4H\EDG=3 U
MM:4=#=@8XJBRM7M2N)E2L@[P ?3X:&:^XJXJ&\PX^OP)KZ4V\E_'&=?*$-J9
MWO 6,">.5)SCV8C80>+,DF,NCA7&1CTL5D*/G'Q+K[31KCQ?4=TL[*/UL;4.
MG/*-:7.Z3A,Y4Z!-7JAU@-?./3'N/-VRSSE:\(Q]''9?((;.&#\NBX\L)BO8
M7]A1<E\RP[: CQ:KW:8]^OG)-CF)JS[IJR-WW,/!*Y- ++HA;3WMG2V-G!95
M;=F3N,B^ 47JLKQ']^_=NH_$?73_WJW_Z$8H^X]8V=^'7RYRJU%\BR#M-PIL
MO+VE#3V [:B6<XU"VLTN'5&KI-C/VD]E),[$P 2,X> D+A<$3^+C0',F/4G-
ML<:R7B3HD\&.3'%9Y_0W('MBYBP]M'9H/SH[*3@QG[/RDTZ@/HI$H,HX39<H
M7U7<A&*S2S#ZCQ-3+&LZ]6$C+I;EIM.:G#C&2#/G-F*S8#06.&MV-\U.TZIH
MZ@8(#BRN!5];8_L@FJ_R*8-S(-PIR-]3#,:"I51D4K@O13FXR63UL6>CIKJB
MUM%%Q)F-5X(><V7--#Y]-K(%4"P:%V/^EXR%NRS>J'92U58;M%OG(=Q_U('&
M"-.09X:#G7OF(1U.'%D%J)]B=-9/FWX:NEG/]F..R;7M?Q3<?GS,>O[($C?%
M6P:X?Y5EY/4.9.(UV@ Z$-'X.$8@*"\7/2LJ,G"F69PN<&/9?3:V9@I6N>-4
M4&%:IRFK^',,,J_,D_-*C']2P$:^N;(U12<;!471]^6PLM_0I/Q6B;&S!! =
MOTPKHK!5+1X=C8>*T$T*AH(MC.08MF>3G",'?=H+$D>7IXT60ER"L\75-Y(8
ML:Z/@GMR">M)D=>6Y^I55-7:6CLZ0Q48+!*5QNB1I;O/VDN^M"0J-.E]D*]&
M?E%'@=/&J5>1GWDU:F1>4=7OSHA#\*=ID=GB#K,-[L,V@$\H]-_D1K9[0--Q
M0W=-OL2\"CD8DU;!:Y6&*AW66L-/V735JY0C)71#1A)C$))'V\_9%6P-]/L1
M*VK>ATHR[L0D0W?E)$; ,7%PKY94>Q*"S-#"P*N>5+VM/1]'(Y("; $D,163
M2JC.)N8Y5'OA=Z[WM#^7C)P_3<]ZJ?_I(@@63(T1<P4PMRY3V+OUJ0YG9!ES
M W+#UF3^U'[OU%]\UV*Y:RU%,ON83:!7Q88L92NMI3TMD0\(R4+5]<AT3F+4
MC,RTN8G!;B1O8*=66AGHIY$MK6]==1\)"C\0'"CQRH IYJ>QZ#1%<LO=1=>6
MY*[@KC3V3499U13L 7&5F.1;8]MS9E3N*H!U;:BMG[2UI;%J8:\'<D>'<Y'=
MTJDRU>?-PIQR.WSHMVTPK=A;Z^8MV9V=&N ;Z]%2V_AX:SKJZ(G21*2T*4T&
MZ4U@<L1KAUA@Q,VPC:L"'I,.6@P*9B01:1A,DB&V]CG..!C%<[:;*&9\!KS(
M@SI$Y]=G81U&"NIP.SID[D$&2WUN.[)0UW33.1=>/V67L#2=9&Z7&>P)\J*J
MQC6<!(NK0CH "9/ 6^<*14<,,8QSL/KH 'RJ57F*%&0W;&[(O3.8)#B7OAN+
M<+F;R<*./N:76 U\P](P-_1]W;_U?1G?U_T?T_=UP^CV>CO%A!U"PCS8&:0;
M)XDS")N'4UEO9-K,_5VD>9V=AYP^D?7Y>+$P5&>=W8ZQ)6/-ARST'M>#%@T7
M=3O@6.O\#@[=3;D;6K/&D*=U*QA6WS;=J[6V.T&EK#?>05:\$:-=V\0-#;EM
M(+?T^"=A&]GB5'Z&D:QD5,!,]K*W-]9<*9W[ M9P=+G&\'!P<6LXN@)CN ^J
MLF4-HYW7;QA&GET8M FU28AZECUZ;LS2P%[T6KEU&T"-5#W?^'-8KFN:DHAI
MU_3#D''RV>M>;TI:35(_:N.1J'@QIUG3Z<V@JUZ5 :I,N0TLT&@# W1C*S+R
MC<CAH-N*_ *C-A!_EFBW5VCE)XI2[ZECPCCF<192B2HM$F; KN/2?&RK1@ON
M-K&5)[7)K[ .S&6<MA)".VHHR+]J69, O:K:L4=6UK@)4.V%I#/J(7"?G95)
M2/R:9RWC<R[[1&>LE4A]MWJ$CBKIF]58SLK4#6\ =:1AF_5C#5H2[*(2)U\7
M#=-H:A)/K-_KN[57KK<7"^A]+Z7S*IQB4P54^.>L ^ZW$,!=#B15FBKO0.*'
M%D1ET_63ULX>#ER^\19</.?SWU?&\;NXK,]]]S]12>L9F93U92@_A\R"]"?0
M'A?*UL<66A6O80L?;4_BG/2VYBP\)"%S7=L_D4E14C>Y=$B6HS)2834J,YMD
MCBQ$P,BP2DV#ZR6B41KERZ27J51 KA&+42FU(JV]/6:2JG@T#F7,]B<2R60C
M.]<V/I")E K7:L\$IGB,[@T-W^S A$J&M6;Y&=C1@#,<J$^%J+Q\V@X/.87\
M4 48A;S):6TI?#B@HD/890.B;2 _IM@RE4]DL4SHQQZ>D13)^MC; CNDZGE!
M2":<#C;'%JQ4A8^"?*2T$=E1H%1'349/%3-,(!$83N1O()YITD63WUH.Q9<X
M>'9N'3S&P;/S8SIX;J9X_X7D^VZNN2-8+KTB@^4 :+*$%N3ZJFL,,NV0ST4#
M+('!IDO\A6T'T.#A: _II%(_JU6<&#R8E?P&P-CEJG:(903\QSE0[!8]04\H
M)M_!W<ENX-1VM*%4O!!56>:&38DUIO;7ZP4PLM%DYC2$H!C6D!2RE5S0X$Y@
M Q'<L1?AHV)\Z@>\!$0JFO&IL<T9^ %%UG7A>XH=9..9^^'(*.# N@P.5;=*
MT-XVUFG,0KMT"B.0U$9(4PH67LJ;@N#*6<H*I^DK@=(P2S\F?!34*T.2W[FM
MDAF>?!J$BRGX5ZWUF*O3HXAMV;:UZ("A+/N.7?%05P)OTF%LT1:2C%K0HJ.J
MZY:V[TO7SO<2LNWML*DV:?=$)>0$JP7 AEX4#*?"3<]:2^BY^^$YC[:'@Z-U
MJYFPK:Y2PZNDKC/G;0SP-@[!P8F9S"/4"/%00 TSB(T6Q(S_:6A5AESEBFCQ
M+2<@>QA&*8O/D]EV!&*S:]XNXXG] ABS;8S>W!1+7F,#7-^Q5 -QKU:;YJXO
MD F)AC5KC'P2"SCW.\&I880O4)46/&,Q):CY$(*A]_%R]D!CJICSKN22+Q;9
M*DNZP*+A @.HI:[6/\-O30N]F(3W,:ZQN*@#Y-ICHQTW-&S7*5'0^X(&)GR?
MD:<"V9Q&Q6!H(HB)P\Q:=Y)<AK"+>5)*)R&\"M3_J#;Q?^?D&IE2D4G"KK,N
M&=.(;)@0#]RT9FFPN8%B41K^UWBQYK2>[>H;G)UNA3))%U3PU<6G7<NXPB9+
MA/46'> Q.H-%2<'7\%7OTB6JZ%I,4XJ]-&U3 8AJ0&,U/'??+AK+C6HAR]XZ
M&PJP/CG.U/%WG+UIUI&\%5."UJ.MR4C*_VU>#&F6874="PPQLIERV?1P0('<
MX-,VNFMDMPE'UE@+2U';3N$_-8NR_2K$W4W\ +E.?$Y3%3?T<!!@#B8H1/$3
MOF\,ZD;!!Q#-<2VZXSPST-'L>2>#0)+].ZXR7M: TMN1VB17=]R902D=_;#"
M0$&3\H[AK,^P5D$P2@T@8Y:<HB<+7?HU;08Q5>RO28.)@M5>D<<TUBW):78^
M)]$-1<9X.B@-:N[SBN[AL:UVIVPPW@!<V+\EQ-4$Z+I8$K:..:Z-VP+GC#%7
MEWNR(@!A_#&AWTD^UMC&A5DH>@%+#"]QJ^1QYQ;"ST-2RKI7R0"3\*!)QSY-
MR.I!2?\Q+\ZHLF2,!:"4&>%/@ER32Z3F52X]X*9%60H\.39:L290+-V$@I$<
M3O[C.S4<!"Z5J(JMRA=[C35=&'!1BR'0P"1TN?\5JIO($$B3:&HZG([=5QU@
M*S--G6:K_-<&II;&( N%V91NXOMXF9GP;[DQH&MCK?/R;)_3]D3"W+==CJJB
M>ABC]=BOGD8 U).Z\:"Z^*T)SR_QUSZX]=<:?^V#6W_M#5/PCAQ[CTQ>$ODJ
MK1^(N8FX&/!=K.];X9W.G=;3A)[T4P 0JI?\7KY$!@X3@>B/J?^J[1+-V6)6
M:W I).HIFJ*%E21PQA8*=Y>6H5%FC!,Y78! 0.V*0TY3<4RBR^BXC)<G77D9
MWOI=$(^%N,OL[TISWCQMPP)67%'>1OO,PFD;P\%EYVWTJD_]NE(CNP-(]G.2
M.D+9&AWG^8-E:APY;8"5;*G8-!L3&_VG\K,E/0)"WUGJ %.,\]_YVFR(O:65
MXND@&!F[AENN%/:/?QM A!<%#7C,H %_IM44[*@X3XI5]2U"!MP,H(#WJ.^G
M!EIMGUF$+>"*(]0SX/8WZR9+W0[%&!/,5-+2>+&I.&I=+>-PH$ "3):DS1\/
M-J#WKPZG* :1V\G9BK$38&DEB%]FAEE\1AR\8SK:S4K-LVAAMD8ZB!4O]6W3
M4#6G3" TFJ3=^\AID>EF.!R8@C'57QQL\Z3&+&0C;)PJ(E8); X(&([G+%#X
ML=PUCALN_O9,+"=]]'FG3K Y 7N:6MR>1A$7%0)PUT;C1%3SMBWJ'6GA2J=V
M:L$=] (BTH6.)SAVN3N$OD<Y:90X2I^=Q::LRL7 *4Y9(KF?4S]8H +>NXG;
MLN^9AUQ=;0D8,N_2X^/S"0$>Y%X.:/44[7-J.DN*0P[6!"7H$J1]1[JHJ4F1
M*N<3@W_:1-W@SM.@O P'I-[8BR\$>Q:7>.TKZ49M!.8[,!.9:'>/.51&'Z\I
M60RU.HJV4J+DD6V/XF-BY0;P@5F!5(Z?1Z9/S9;QLL5^ PWC,YS&RWB*/[ &
MA($I1F9H0O\:2=!C)399OV.;H\;P':#&X>+2=E,9-89RC1*\*1A0G?@L@E.O
MX"#7PV2*)880J:"MXZ]<2YX &J]QV-BZ7J6-/4:GN5O54JC58\D4#Q5\3)NG
MKGIXME<]EQ045>:+A<.&<0X'CH:J I@ROAA--J"C,WV@C;TI5&())5*PG K.
MX2I4\RO4PC?T'#V\]1P9S]'#']-S=(74>#-R]E^!:5,@7B3*K%>N$0=+Q1?G
M)$OB*;=JZBT:&FL$+E\?(X%ID =(]>-X^G!@&P,W4%*:. _G/M##QY1@5*LI
M&,,=0 ^1[E@U]OPDU "*8@F<?NZV8#AH]"+IZQEHH+HZI 9#;7-;6 +I\LNE
M&I4!#+R@JP'( :>W)M232D7[5:'3%H8K:V>\DRO(E3DE,]MS+IF-(K^75;M7
M%B@\7](L*[IXKRPA(LI%G]H85R6250/32R,<!^U@O&X^%+,Z:A:3_FGWN*E<
M68E"6Z=@E=1:-4T6W0GK>U;UKRY!8=<I/T@!?Z&=94K(C]:8B,UZE\"S!L=\
M3 0J_G6Y%&":+XH91^R\"D%,%^+B2)H,0[U3<E[%:4SHRU^A^6 YFQI:LH?4
M>%BSDMN\.INEZBI%%,<@+ \XD3;4LO$1&Y4>QGAT;_O^3Q2A+DI[*2F!HEC5
M%CBN@]BWT$J6.LJ*S&%4?&U,4M#L3=9?'X2(,9JBALU$VX8[Z)!?S,_0P/&2
MJ"BOUJO:M,=CHQ5R('2A;=8&!Q+\2I84=@S3:JT_"7NT'(.D6.(T9 ,%,UFE
M77*WA=;+X7SH?3#3OM=I9&IF1EP UR4Z;$C%:.,&P;J;0?EM^&*S'U['LAEF
MX ;@XIE*D].T6.EK49M6BZZ/26_W7&<Z<*99TH1YX(=FJRDGS$O0B3) \%O;
M2DQ\4OYOVPG*"&!^G%-?9&+[8OBJ.0X'NGV(F4(A4(9T0WNJOS%=U\=9I'H&
MTPAA[.VR:NG.3"#$ +@Z$=,*&VT#8I/3*ND\G$B2?*(R]=/$596+@\\+;&%W
MD$7B;9\?F&-TB4SRL,R_P$SFG&'_O6Q@FY>)["8VQ>7M3>"H4G.=M62*ZU 9
MB+Q_E UH-E 6_Q3][H8-(,\?XP<GQ1D"A?"_K=K1P]Q#O#TRK'W<Y.U8HT)N
MH$#J1&@@H(:T!)7(CF:&=_8^"'_,^O9BGXH4$5,VD1P:3EAE#"PN+L5_XJ0;
M!*;ISN>#DNYMIAEPG38EC3^Q.*L*@A[C>9%JH\Y459 TG,O?L8*37*$O$XT@
MTVE&@::R=>3AR2\6JUQWP9 >$G@:5L%%*K) K<R3K2!MZ*^4(^U:_L2M_*J0
M!_)[/N7YE?09@T,^-+W?F#/O5BBTK!;KW4W34$<@H?$0N$&8!#$H?#!)61:Y
M&+L_@*. F(>BD(H"7;:WV&'#=0VII+!OF!FNRD-$6\(V038LDO(X*4<Z&H54
M[")SND)_HXH7Q7^4I/D,==8'G,*I\[3)?>Y'$&7&;H8&^8E+$*1DCVZ' #K'
ME=KQ1J;T]B_6&OX^[]*&;M1'MVY4XT9]]&.Z46\>OS^^R@CEOBY3LE=>F/X!
M!^\\ [X1NSM<34 I2[DC$&9U$5TFW(A96 I%>$RQ=5Y8N=Y(G>AXZSB27"Z+
M6*LC1AZX1<Z)<9(X9)..6C:,"CHRICOIYRH7FD+R;'+@C&"*J>U>W<B<$":K
M0I1-&%>-@VOJ@*N0IFYLKHMMO#&+$:6?SR"T%31M4X_@1<AD70S[KPV^5J!6
M568;[=^V[F0#!GVX5!(NV,:(\_==B)&.*WIR95=T[Q/LN:V+>(F)E4F):E%8
M+Q,C.*%?28[=66&=:U/U^[%15]C(/3NQQ2)U<9QPT-Y:?\;VHEAK8KUX9)?%
M7K*+^<D4#7T7?:;7Z^&UN]]Z"DF+6]I*':OU6\<UVQA2XML)Q$9%_T9WS!%,
M@4K[4/]3UJ2=2R/!RWKLV6>#^J9N.DK!CN3N(DXSUQZ/O!P2(ME>SN82&8FX
MK 4Y5LR) 7*)J6*^+,!.4J.0LXMR&BUS^+!]N!W-$[1ZLVCO</_W P;>GT<[
M]^[=&PZVDNWC[7%T=G:V/2NF*WS7-KS&1)'<NZ7FC)*'8:JG0-8,E6>4=#\7
MV2C?YT)*% 9B).>SDX)2=@G/V1]E.$@K2WLCMPK:\!:"=%Q9%(+ SKFIHQ+!
MR>!8F0]L"LL^\;W$*[]CKI)>E:'W.^;O$3[LF_C,=8\U96N4YC.5)XQWN2Y7
M4FU%M)/B!4QR.E1[]PG98HE=%L-MD3R#WN;U;^S!^DY-DX[3__NJ3O_E:K&2
MHCP_S?6(2BGY$]\=DW)V]M3]TF ?6\>OS7:5K*?F:SC#]'L^L(]7I@0<$N0T
M9\%[F(1XA\;NIHPCS,S-8]8Z$6.FE)+W]E5,T7>0;58Q3^)W@@$9NOL@>3-J
M)0F\H."RRE4NO  =&AR2X@8"D@=-/A"LYE.SK=QTV<.C)JR=?$* PCO6]270
MKB),'#MCC2@6R)2Q://L@Y0%Q398JIU.@M;*+Y,F+"D[.#$VB- #.!U;R:FR
M#>9I/E,8WBBXXHRZN=+E071N5J&G)P(7)$*2O/P3]!+5#&YGOY$"U5@2GAN)
MF)(%O"D]  $)!5!F,E#U<L6O8K5+D@?YU*G<B:IW&\I!:K*O:X)>1O,)F]R=
M*OW3$0+)DL^B  MNX]50FPBG;4 _8=N2S4,S=8Q&;T2KWS-#RJY*@OS!F-I*
M;)S()P'[%P7'W$31\Y2#3SG"Y<\*$B&D76"_E41*L@V-[08,"_B!Z ^F(ILJ
MK]E!8'&%VIGYW[^VN+BJT]Y7[>D/6"5W"0.F:OVM*FC!TWI/W@1'(!Y>J>>N
M5RYL)!5IKV 4C.& NBLXM;#Q(J=R--\VEE<$XOJN';,D@J.0, W+&[4JC3$I
M1-$]* 7B3Z@'NZUS<V#Y,EKARD",AV@FC9IUH*N6JLNBLBB[>1&9ULYLJDOA
MJTRCD0XO94.,I!_ ,E 73[NP8H.BA3TC3]+EF,17514@\]@"B+GE183F,IE]
MQC5%"Z.,1]@ER2TIN22(@2>L ;JD'+NEJ\WU9E!Z)X-+9H0EMDL$;QG>TAAB
M.&AZ^DA4-+!R-RAJ:#KP5'$Q)3]43ENPB4WMK+_FDB@,U;^6]GM;U3PVT9WJ
M<<<MYV9SR70Z>KV!KB;-PBU@G+51ID18JC"9SEAK][[43E+5D4+*I1JP7V@T
MZHHEF(?K*#'W=MYU2\#B\H*N%J'%V+(WX!H.3H*3"PP"AL6RD%0Q 8Z1+- X
MPEEF28_+.,!Z]"FYVXXX%])9Q'2\X 8HC9^,N1 =4=&DWHM"Y=-4YYF9'L&F
MR0&E1<G;#;_RY&J[9(YW=1IS8JRT2G!1>/P[*%WB8@.)7!4^4S&JHFN2H+QM
MW(V%X$J)XME_9W,ZVK6^GOTQ2>JS),F;4\:FLV;AO-:Q6DGP)]Y5TZU46S^D
M&5,>UW?1ZY[#@'>>_X_ _RY[2*MP7'F%@5E56Z$Y2Y"Q/,%@R"+.X(G]YUN'
MSOWXCFH_7P,!%&>C9S_O/S=:S-7.T]^,-2'FQ[<A9A-B?OQ-AI@O@8R^IJ&P
M?Q#]M7]TL'=X&/WUQ][[O;>OQ]JB;UOP:>5GG;)JKZTS/]++B88F/2:>@(5_
M>4RVM7-'NR_>[$4O]]Z\.7RW^W+_X/=_WKEWA_[];O?5*_-O&?0LG=4G..J]
MG]CJV6P&<M=0L,3+"HC._.T.T<JSH_=F@%/L$#J-,W,20)!W##T=O;)SA[_:
M#Z.7;W'J!_^\\P H],7SW9='>V_V#Z.#O:._WK[_7X?C:/_@)6S@B^?T._CC
M_66/JAZXI-<_?W'^I&O '7L<ZWG8%\VL<>J/[_UT)[P7_G,/-WOL$3Q&'&V#
M9Q_<_^E*=CGXX1&J\4^ZGW2#_TR7YTJ4A)UK4Q+^#T9%=X\^O-^+WNW^OA>]
M?1W]\?;-J[WWA]'KMV_>O/WK\/]>&?=9(^I_N2X!?V&QW2'ZOB]INXG2=AT:
M+#W #8U!?7T2K9;+I$0,%TW$H,0VJ/CH;;1[>' 8O7^_^W^O1Y_==-9F"Z]D
M3@VUY9*/BWFW<V0^B?Y?Y_\N<5"P5\Q"]B]OQ^B]U@S"1>VNZI.B3/\+%#C^
MO. D%5XL#GY-"[ZR8PNML&=--WE))+ OL*;+6U0+],U<OOM?2XP?@KYX<+1_
M\&'O\J3W)1COO]Y*])LGT<G93+:3F<F+JY*0;BBL^L:^KM$N!KFN<,CKU5<^
M/'^7Q>1_?J7Z[_(2O]WE]3I$*!H2ZE2\1=YY!WP1>*;RFF**%Z3RNQ-[&(!+
MBA!QQW+*>S753;8T"J9WU[:(6L3GW/A\.*C3!1<^P7_'U- W,HGSMNP(!E"#
M$TQ?8O'G)#2S+-,<&Z)EMH/(GW'Y,6G$N2H"$DND!SP"#\@S,!'YV3R>VAXX
M#LVB =*$#YM<&QSZE!H2>-&HHY.D8OQ56\0;(XS6)_Y=GAP7=4JQ.?C]%(ND
M=LUQ#0?ZO/#'&.:@5>1)$U)@3FYAG#DC!%><E&Q:([N)/_D:5-CIUM)NK*:;
MZZ_]5T=__/,.^K/N7'2JZQR[:ST4;7>':?_#[H; USN\Y/_^V^-??GMJGGH.
MXI'[VD_*XF-2HLCPXK04Z-$?I)KP^$=W9PD04DD"=8HARZ4DC9:5\GZ$/1\;
M[,?F7L/;$X7_GV3(18@'])X6P1QA9'VQY!@V<K<F-\'.B.ANQG:->-4M'(YD
MCA%'U&V'B'WS%*@^QO ]3-!CWA5+ZH.BJELJN78J,5>TXF14GS2\DY.3CC,+
M9^@_3(TG" 6,RCMNS_+:SS+.K=* (#0. KPCR[]<90Z?4T&$F9?<'N'U7T?6
MTK"'O%.]M-R]/9-K/Q._469U D*.->;;L[CVL\!<)JV%&O1&3Q29?J#4'\5R
MNY %:?6=V*!]8[VBQ;&2!J9.#8*7#@<J8Y^,(LQ:M3C*MS1Q[31A:  /V8#@
M8<JA=VV+I<U!92/[))D=4UV$(B?75,Z\$]TQ\DLK6G51^>UQ7[^6@U5 $],Z
MM%!=FHUK 6\N\ %LYW9[/->OA#9Z03G<&P]ZT*F;7)KX-<_I&EU-1UV2"*QJ
M1*2O1"!530#A]Z"L1_<?/O1=A<FG1!+Y"4?0 Y4P[3T\8#VI8+__VX,'!!,B
M:'=-G&&-& D_T9Y6QMDTW03'",]H$?M51Y&E1?:]XBS?:PE9?\;(+WQ5),F/
MXV.I$^Q40PAM"AM#''.]%A\N*S65TVH*3A1$>[RF*@U20[>CQI#X-FFU1163
MI@EL43*R,5CGE<+4#LYHJR@MH&K#*4"XJ,8A9"MWC*N/N*]"^W;XEN:)D>N?
M5IGJ5F?MC-''-(X$*JR).!<K($:++^A I&U/%^K.0[*!YCD]UW)>>H33&!57
M,@T'4SA3( // ^HV+X2'^GK_X/TNW\N=^SOWGTH9OC^^=GVI&<3DU.?Z&?S;
MK#C#,;!U5^\@/]A=V@@W[+?;N/ 7QX5_#'+:#W?/1BYJ.TKISC5E9(*!%1?S
MI?FXFV4BVU4P6"$#@\=L&*NNZ3 HM?F4&DFG4AUHK!)TW7-_G:A>E;E(%1(!
MSA\1B(':,BA0O8@AV5DA1Q8G?L5%Y'&%R/M<,AJ*\8F8"JDH/ D%&X1OK)(&
M:!664R:1(#EBN)1^96=!18I904 S$JMM+(>E1<#4-]N"$S3Q"V]X;U4!V8N+
M4F?'-I\[F=89#@=K#S'29ZCJ+W5T%": _CX4U&JK^+BE4HQS^PW6D:DQ]$:G
M*L.>T7V1;-&$3;7E4HE/ 5U6)]L:;<U2AP-6/^@86DUFEW[WB8YF$]S%:(Z5
M9 (XX/;_JKLDW#2>U4FW7*W75,^(TD@U,UXPJN<]+;)3+@4T(?<&HY#@ORM0
MGEAS@)1Z=*Q0R3DC1.$=,*"G29P3JQ#NTS V @UMV:W&JNN^M!4C^*\Q5UTK
ME55WC&V3HEZL9'L,!T!BA$LKQ;");BZK%FS44=,E81'< KMV+BL/Z])!2XOL
M)BGW#26X(&Q@BN6]B\0O.C8-G2TN.]4$43VVE/7@!:0R?5TF+96A#'$[CAQ\
MNX?F/G8MA9<6/-S&BIK\]@>\:N84_(XPV%P:"#,IL:0VFIO$(=O)6;>NU&>)
MJO_,FBJ);Y^W:-('3SXA&XOK>PO3X7?>9T7&QS$R8CM/[JLYYF)U^*_ISXE3
M-YU]R49S)>7JXT[_P0]&%7\EZA@^)LFR*<F& P>UR-V<",\P+K.4S>$M:C-E
ML%,[$K9<^Z,BLW04/&93]N\1$TD#]4U<FC8!$?#^%<,;,3[UW6)^EYBBPPVH
M_)ZKQM<T]J"WY3XLM-EOF99@5"DC60 A2/VD)EV@ZJTF63H5MJ>=5-:YU>VS
MTEXO#%R34@,+P*[K!BZVA*V&O590X%IW5*"7N,5]NDEQ25,RN&ZTW7HNE'0S
M27@FU###1!QT9T50A],I<IB9\04Q4 '+OG3N6)1@N#BG*O5<U/25Q6<L;@UB
MPYC]#<(KZ/EJK&5F=S:CZI9!"W#=(G0G,7\E_U[!9:/X&N%!Q P XV<>8&R-
M[@CN;-.WV>:?]J72UT(3*'93,SY*=LQ40IN($P&$^8-QL0]- N'D#V(;L*L$
M+:@;8B?8ZI;C74#K8ZTQ&(^F')^7:2+7KDU!AF3@?JRRFEND$UJRL6,YR16M
MAX\$-X;\5,RA !S(E%ON<J:L849Z=0)FELRD]QLYNV?)W"!BO+=KCOX<^TU1
M"60N9VA-J]7J53:N40^CSG0'N$;8HXVQJ7?<(FO0.:&BC]E7[IQJA;7DQ+>_
M*N<V8)PNRK:#OV%\=!ZYS"_*@=8.!&]W?5'4\ AX/)#I8SOZ*^&EPU'BNY:V
M"[#/9-W]E(WO,G.8IVAE>6'/)1?!;/P.&!U<GH>&PT:$,:/0B*<Z)A[NG3TE
M>AO9@22\Y39W<MYR :.0& [N_[+3*25N@KG:[S_=@1>_Y1CW$YR)]*7X+I$R
M=N]>!"MCYT>%R@C4WX3P:*ZM^*=C<*X%>O$U1K^>PJ 7SP_WWKS9/_@].OQC
M]_V>%"=_ZW5/:VUQ7PPE++?F%@>>]7LI(#F)R^1$X;W5A)2N^C)@BTG7,B+T
M.X/_AC^T#2E[G\?F2M@,SK2K9+EQ1I'<&K3MUR@>'4":MGO81#...!HNGQHY
MB3.@D2K!!7;;P&AD/ !6(EDOW3O.'!T.W@&/M6E/A_8M+_DMA_8M?\E;C$N/
MP6)0>.L&[]95&)X.82L*-!PG>NCMHB8&[ES0L8[GIU\X9W!<%+6LY:M*JVW4
MB# *;!2\XDQ@$:V([MXD?1)C=IH$B<5VSCB)N5P,#@B6#<=%+091+.* ).Y7
ME79\+N,*5XM)AN=@[?^(WK*:[L@DR8HST#$E3 :G'KR5B$Q)>F+W/>"F8A12
MV/2L3><*:_"WAQ; 0;!&"IC#%-TAN9NNSO?L&,+."IMCGNE^&8'AQM&$W,J8
M-(!MS=0ZA PWN=F,ZV2*S<>@I>U0PDZU(OV]B^=87/%.>A?,S^$ O5'C*.PR
MTIXAU9#WAR3QD[1L$XUPMA"M*#$5"+'UG<T/MKO[X:H4 BIGJ-]@DZ0&3FBW
M=&[N_#%<XY+N,+FSJE!\:+70#EOF##27+OFW5JLP;A)?3$<7E-)P;9-J6J83
M!&!%@4T/D=>38G'QIW0!:UC+TKH:;AOW#:>W.W:D6H90ZQCF9+JIHN5 U"W&
MO-%VH%) =::&>8;Y# OL5<$5+TL,]EE1,./Z0(K#*"*H;/?K,PJ@I;4T \ .
M/S.5[;_W<LPL^G,'5BX:T^S,K-ZZVLG%K-TZ,Z1T=AC%JO%&:H*033)V5+PA
M"Z:00J>B>40EUBM,DF-.A=/ ; [3PI=)7#O&#5TH1M5!P#V.\A^,8WVP3AYB
M4LUS&"-Z;F +K?/3'J GLH5YP'C4IH>BX>9![HO'",)2C1)0.$S3,";_%-,J
MXSE<B)3Z@Q.]ULY'*V"38P[:^*H-\-RUO$-ZEM',,(42R.?A]F^__83.M-_P
M+YQ8;*_1F!@H4"<NT^_$VG#C&HP ;P_&W.?&0DD+BG1E"W3\V[F&X0T'+8XG
M+<8-^Z+5^?WT+#?CF];:(;GFHF#B?GN7L3+=%DQ."]ZBX<#=<'YM\/+9C"8X
MH3%W<$=<!DHBLK 3:A:F*S>\:!O(W<F= ++(M@B5KW^)UW@H[]]F>-X@=^!E
M@&>83>D"=\4,HPO Q:[%A.6=#>"4>@C7$[A\FQ".P4.S@0MW<YM5,X'W+]$U
ME!^[T\97=\"?!@!< V\,D>\&JP@P?$\/?4LF[SL3)WDK_*6YQ.!ZI,&)GJ>/
MQOI-;-&?HE>OW2K.@SC$H/B[IMKDRA1^H)W;D+AVJ8/4Y5+6!CB__$)8!\P;
M>X#D,^1%1?DD*H\G6SOW'HYW'OPZWGGT:-0#;?SPIR!.6?BH#%O;#.?X?N/5
M63)?]^;?+C2;SQ[F=@'7O( OHN:_3M(Z"9#PVFGV;M&F^[+Q9JQ[X>ULUE+'
M%<"*AV>WD>*^\^.D%KRX32VXY/CZ-7A[>L:U>04OKSNO8)-UH[9S:>D%&R*.
M[T[K)$/'Q4%2GQ7E1QAD/Y]NKX$@O\R97M^>A"HV#HHZE7ZW_R'=NG/L9OOU
M5W[5,3"N+4'$U)GR& X'%-MLN=H:4 *F?PTZU%UN7!.[58@K\FD+VQV^2K+X
MC#I@%^6R$"=Z8PQ)0_=@"H8#5Q+C>N5ZY14<,Y R3WJJH,\T:) ')VLS-%^Z
MRO#V5.0;/1OT#'?$,3JVBYXZ-$]YVV72(9H% ":8I7+J']Y_9+S4C=*DST.!
MB%H@$/+6\.F.NR#GM-]\..AO;=2W,<V'O?V!4S0E%FGEVGMB2CAR='3C[JHT
MT;43\7+);2ZZ(23R)TLKOTB(#.Q5;-BGL LH1P+&S;)H&B_3&JX>0LWS?J!O
MV$(*88AOKIN7<H=&\DC7KMX.,1@D$%A+RU%Q0_<NY@>+V+PTI5#8AIJ:KHJ*
MA2&2$@, =)X<M<_CA?2U=+YXQ?]#VVLOJ,O73@PTF V2P>69$K[N,1;@Z7R8
M%C.ENQ&^4Y26%<].*:HJ'62Q*SG' #!VXU=[8-$W+#=KI-CH/<#!]-(189J#
M'E>Y'3>/ B]34A^\/=I_N?>CZP0M0=)2IYH*0 ?12\51@G&SB@LA,1B8] @?
M3M&B%-&T[B?3&T"+:RSH![>AKYMGKEYKR_GV=9,[(5DFG.)A@^>('>+2*R6W
M0+?K+1-L)FQKYET: FK(% O7+T@)T'D%%R>Y8FC^ZV32__%A[_!H_^W!P>[^
M^Z_!J[]M8, >3$#C.KFOFF;B_[^@6&FCD^8M).-G0S+V(S+2MUOQJ,]W;&_;
M:\S*>T-Z<2N.K<6T<R]O-.4>)_FZ&;4=VA=M-_K;9L&=7]<\MDY^VBR%7Q](
MDL+="LPZII(U3"[LM;\FUOK]WX)V^W)W,G!')B/KMMR ,/M?%KA([UWI^Q_2
MSRB=DYG/Z9CP5(P(2"-.XAV9ZO_A@!T7/18@)O@_\29_>SEO+^=W=3FG5WLY
M#[!3)_S[)3Q;%EGTCF$-MJ1</HFQW5&4RU-<U(X7L["@2I&'J13%F6"ZD9N3
M''D5^9>7Q1F7QIT6C&HQ2ZME487@J S"AJD8\2(,H]L+_VU>>/KSONWLV>L=
MN'L5_3X;$_#' JU\9SO:%5\U1A4XQ$5^EH N^.12(Z&]4^MDB9H%-EGD9\_'
MRS'MS$5=FU3:(/Y .MUZTFTQKB_J6'\[AT!VKV8&YN0? L\Y2K)D>0(L_,E%
M^4[7ZW]]_-/5+.#.\[V[?\9I=EDSOJI9HHB-I[6(V"N>[>6Q[6MGPP\LAOLK
MQEA%#_6JN@D,=X,L_@NJG3B3IMJ)GRFN? /<)+M@<YT7JV9OO/_YC7:L6#.A
MD._R7_#6?_SWWWYY^/!IQ-/XW#\/"O."J^N:?BE&U;=,T-?H\=B?F]C>>6+Q
M0TAG9)3?!W"Y$()V1C?'M*(XQQ+ L&>#JF817"O)*XX[4#?)_#3AJMIH$N<?
MN5%P>6HT5!78^)\M^^A[OY21OI71[;V\XGO9L9@+7M90KG__C0/#+'ER%1<X
M+]KW=SAX .QB;"Z8I+/]HZSPN0I3U^9SP:^>(?8FI2#%-5WVZH3J@A$,%M4+
M1OS$')(\4CCB:Z/R;J&PQ=WW^6N9Y=\(U7Z)>C3]3/4HCVS).3>^^5'5I1O'
MF2^PAA^.W-<H3[/+59[HPF V7_^E&2-N #Z+(,WP9L=E;?,"QF'I"!<)DZ74
M0VQLY;K 3%95FB>50-[%%AK6>J;- /UIOE+NRICEX^$ IX8P:GGA\$VJ5G."
M:MSA2-^D.4%X(K?ZWU?G,K?ZWW>E_\UN];]N_6]-SN;#'Z?J\>5MU>-5N6"O
MVN?\<#MZX> VWVJX3>V8$07 9)"^-?"7'8#MVU_-97WEDNO9_O.]0%=21C\5
M\*7A8!]X6/20F:=.VDTKF_^C44Y+KTV&J:>CEM:Z8YMW!M*3#AON-K((',J5
M#]J6(!H)*W2Z$FC_DD_J^Y/[UQ!@0%9):O@NM<2E9O5TP.I<PPBT'5?PR3>2
M)1),]OC"#)#+C6M^O1DJ;><:1(&9PG5Q;ACRT38H?PY?NW(EHL+EOE[L\ZL*
MDG&4)RE>?[;LM03)3;.5.0%+.X1'+,8%[D"@MVQ+%]R:Q?6>QLY(];FM/=QR
MQ8:/?L(_J1NIB!EYMFHK 6HV(S( "&V:['5IXDJ]"6DR^#=Z1&#5F:?U@*MK
M";>%?H$:D4:368)-NGE!&M9R%,U6%IT^ ,7^%67;51&K"!:RDVA/N4DZ0<1B
M3=#E%>BLF<%-E>472EKQI?8&>8H;//D#"JJ;EW3S!06MY+VLN/%G"3P)796@
MO;,/5BGB<[]C1)ISK=Q4NH<S6(1UQ.JZ.@L1+47^Y$!!L-<"WX#8TERE;11X
MQNNGIW'4F@8FC^W9"2)6])1BE\D"^X)&MDOE4SOZV.%BZ.4SXH!T^%-M4&4/
M6#0U-L&L5>P-A9&KBWDS@MOP-%@]L+!]Q^5O0('N=8[<[[5[ 3N/&T7-R%A9
M:&X@5?<K4&GL49P5U<I)=TV$4TS/TU 3*?>LB//J3!JVH#E;1?=-@4KTB%L&
M\INFV:HR_<5;A:,7A >(Q/DG_9P9FL0&$ES#\,K 7O3OF?3^T'O4@H5IS=TT
M[H/9H?N2$#Y:G7U;;:U)$2F39>SZ4]K)V^8?G[\?&V_$.B2F[_/*[!]$?^T?
M'>P='D9__;'W?N_MZ^:E&!,40+RJ3XH2%=O9"KCY,?!!F -JJ(2N/N.RBRZ,
M)XET)9^ F>'YX /2<A#^Q1H[TH3$K>" "'V@XL%D[/_">!VU*[\);.VKY]1O
MKMV\HNKS#\\O%N6Z"7\BVD5#$;/I\0^ LS<<L=_)8B_%(^1MU*6[FUZ<-[/2
M+U"V<.=BRVW8%8_O;58G]7"SQQ[]Q #E3S9X]L']8*'"%=@?SX_2.FM66H2&
MOCH@TWX-[!IZ63I'T(OG[][L[1[N17M_[NZ_B7:C[7>O7@,%OOM7!'+LZ _@
MSV__A$>.]EY%NP>OAH.]_[WW\@/^BV&&\,/( [.(CMYV>,Y",;Y++AC]BOD0
M7W'HEW<?V'%5[!#Q]^Z:^&%7H+=S(#]&H7ZM-5P5$*:W!1B3V1>,;\J?.K[I
M3?+:=\YNV\\OWK[Z%]WZ/X[^?//\_P-02P,$%     @ <(&H5IU0?CE.10
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M7.5;JML"+7.RAL#FR(_<YAU8C=NS[(.C"8I9\M628:E,$):>[(E$_2;+17$
M>0QWR5525N).)-%+&\4?DTH1!F)^P$6#^GHU+TEEC= THLN:E%EZ<56[#/!G
M:/ND<<<E0^:SN2GIHLF:]G24ECGY 8V*V6Y9PSU9\3U,)+A<D)-*E"]A-6.P
MV'<)ESE=M:&DXL#B$4=N%F<ZO+)+10%C2.M-\/HJ09KFETPSLL^3FX3TL__>
M&CS>WPZV_K[]/_CYUF [A(D 25_<,\NM&9+PA6HM4JHCH_7(Z6^<(\M]"B#6
MY#Y]IL*I< <L#8AU@ 5P ?4 ZA.^1S$FU?AN=^=Y6S3ST1YL3?"W^H]:AR2C
MWVK++]AC 9SPRX?!J=%KE%<B2*9@DB9P]%*PUF;(8..Z/V&U=9^(#MINTZ#V
M"H2]=FX?U$J=I0-:6SD7VTNY.J)M(SW(&3".%NSB-8?=6P8<1?3)W'&8H#&*
M?B?%:]!48L-F%J/3&1<GYQGDU#R-"O1IT&^N<QC!G.F:"^=L#I3[<7=WZY),
M^#/Z*4WA^-TY2K?I/+TBW=/<;R#$8O@3G.72^K+[O32Z+2E"1/16LPW9_21R
M.)]IY=I(N#@A+\/68FV6"%HY@JVDY2R!&_(O'F<_&8LS2>;CW><R 2!V-DIF
ML%PSE7=1\3&NV-!&:X&%UWZ:YRCZKH*W.Z<[_=Z6N\?M5W[\K33#FLO)D<2Z
MGIAE%,GNR._N1J0@IF' \9SLXG7XI<%]R+R>0T#L0>-^I%^K$!_L?S9*YV.R
M8L7MXCWJ_+NC-&<S[+=,;'OU0<*Y #,RFV@NNY-$:9C7[=*E2;5E6_-[!,1O
M)R#.J-]3\S1X"8(E.$C"?5VX3];5\1ZW*YJ;6Y=OW?VU;]UF=+C%M5**.2)1
M"9+T+T%SS,8;=O@:V.'OZ[+#4B<B*3&W^3P=HWJ?E"!S4 @2WB76<4'/%D'?
MZ A]E>2VP[M @6,:#XO$M&;8+9I?OE&"UHA[ (PP"D"@/RQJ":WL/"R'_@X+
MX<OXP33(ZS(:?;PJ<CC.B+;,BQ=HS54Q!<7E@@ 5J.E=X-T(!8VSH,LN-,K0
M"$$0%4573:07(P=%69D+U'E71VDT+PUGT;V*4$J\N9*FPM7O)27;NFE"H@A&
M1S.1W9Y13?WB^5R"!C?KU.",L4WZ%?#I/^=QR0@A^2*+D?$KI4SB4D$_J"F?
MHO'EVASV1NJ<>:>2N'5)[OJ&=D6 IY]>/-L-HITIJI%M0"S0 YZ_V'W:#=4"
M>QD5>J#RR<7!?^WCA/ /?V_:*)J:-WDZG^*9Q(@^3AYD&?H)'52IE<1THDDA
M6D%77&UM/IY1"),>M;*&F3;2&$R-.I%IGV4]+4.@OCKA1926)[S71PP:R-Q>
MP5?H_#M-LH_!"1A8A@5PA5%0)M,$U"I$)UQ%F81 ":1W%6<CC$&.1K%8)WF0
M5##L/!M5)AS!H^"W/*EM)O\T+RORI("@=(SM.1P;,R]S.^>0P!);XVT2R1B_
M),F)8<8RE+!!4J",P84P")($;KL[D\Q$?<Y! *.PF<4D<7#;B@@$,,(64U!*
MV9R\RG,0*# 07 ,B&PR&J1#Y/HU^S0OD5/2/(30U=J)#H:-H/W30#O=1138E
M5H0WE!^1E+7&:)7B;^)/,&6)-_+QM2ZL6918$6;BF?>-UO]J_:OKA%2>OH33
M07S] J<BQLG+X!?D+OCZ<T5<UJ=+$QE=T_=:ID.WNR:#(<#+X&(Q@W4.BN@R
M&;T,CJ-IS$0ZSG'I3[V8B_D5?K.)!_TA67XM[<DY=M"%H/0FU$))>'P1_:FF
MA-!ML$I_&D<)B-*E]WZG9K7VM?_OHDXQA]Z34H4^[7NA[N]5JL@9UD+JSZU4
M]7NB505?6JF"F2BM*F"EBC?_\VI6,)&::A5\$<VJWVNH5L'=-:OUA.M&_[K;
M970TZ??JT*."O3?,-B1(G.?$>E;D0D+P'O[&1U<%#ES5YN Q3NAG<!5M_62
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MG$F%*?(,U/;E\8^-Y@"R50M7L,]H!X!:^WG^L6Q"3LGYCHX.KA^"&F.)9HK
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MI$.;N[^D3D%2V2ZRM0Z,:C8MG61-C*BL)/Y&QP",-DDYK<4R\2,) OEYS8I
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MY'7PYN3MX?#L?SZ+F?\%_#V6/,>B&S%G(JYEB-#SQ8M@Q=%=^Y\'W^"C/0<
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MAPN.)H*YTY!DLJF!( ;TH6Q+;[#0XRW>UTV(\L1D6,FPL9?ZA+E6Y#U9#VK
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M*6N"'>8=8<3!G]V537=GU=WYM"Q YJ(4.K1-0Y:ZA]R1TW1K]FM@N>9IZ-<
MY;,0HR522@%,*6K=,%L=Q8PX/)X D'P)L@)'W(JDL!X@W^ZMS"ET+#'NNFXL
M'<=^MD!/[?R=UV#;UE,I)5<IV]F'%H1&\N.WW.',FE*DB0(OF6.D<3H-&V9<
M: #>R)9I'R[)01P2Y(6Q_=;'UE0$ 6Z5.Q@$3BT ^PBXBH.M/9$ZS JY6W/5
MCO8AUS-H!L$ >=C0UL;=;4S0GI=B^(A7%YXC.1*V7F/T"NM]$O['S@.WZ1BK
M1-QM*D:S'^&?U3%:@7?KL+E^;Z6.,5VI8S1(_^$*!$(?UM<@@DX%PFRF1 2;
MQ^-6M4&=EG7TAN!6M<$9^P.4AGYO+:TAN)/2X-\77V60J;5I#@R#Z':X$0;;
M4QQ6##<P<4X#@&K^J%-IX.(Z9K)>96RKA.2GT2'L(/=&B5@OWO7S)MXE\:Z?
M-_&NK^IT<[.%%XL\CF:2IGIAE"<5T+EC$"?DHN*V/YV30[,E PO4OTA]0K@9
M*LX,HF/XI*7 (2Z7?)(59XLE%)U@3"?="NTJM?5RPBO06*2)V-DV$ANQGU;@
M"/32I:!+E,M!YY3=Z:!]'P990HI?EDXP'1<YLTH2#74:9LA@,S84;9M =[]!
ML435CM#'BK2L&>XOR;^6M<!4(W=(!/IW*2"U-NJIL(VU"_:"0JMHS91F6:MR
MJ%,F<Z)PJ/S)EL(@NP$IGHM#9ZJSK51'M^0(:TV6IM30CZ3S 2L Z*XT$[.F
M!*.ENAK*5!$5&W89DX2R]@O+*8GB6A<NYRY;)KYFS>G'W;_J<RFGRPYW^('$
MYN/]WG7!K=! -]-%SB;\.Q5M].).%.+Z6#='G/GBZ6W86?")W^0-GF%C47_6
MAB_CRX);N\BJ0@6CS+8TM[H9C$LK$VJ@RE(J>8=NK+7)L=G88-6^<H1P?>IA
M8?!;R(<<9C&;<7:!,7MYM?K>4#%NUPX=+RH,D59.?.26-"-V5]D;$C:V@\WF
M;3*;#2-L-8H'"LIO7TE\FF'K\+#*/;Q!S7$LRKY<(/]Q<4A4MUV*KC!AV_4(
M;KT==N=?YM-D:MOVO"6Y D]PN3$!<?:S5:-B,2OR67W#!)L=-$N(4@C.*ICO
M%GAL*['FA3O=8F]N(;"TT(7="LQ9*)-<NB'3KSJ6'K:6NM/)JK?9Z<A7'$QA
M<4O1EH&/TNXZ SP/@[!#-D+'BIJ_6"G]1=E@BRF*/]6]I%J4UPQBM7XEJ2$<
M-N,P6D2@4A#HB;S8BR,-,]"%,8@,XUB/.2U_>(MIO]KLPHX](-A_Y& (UZ"0
M*1BX*K^G]8RLGLQ'VW0UIT$SM42["]P*.TX\6]_G+AP%]MPL8%%>8%\A@O5*
M.W8NT.UG*4BG"\IU/,[5#A68QRK)@H*A:FT:JMP/W7>O-3T)9B^^@9;5PSQ5
M#?BN=1%66/<&311L6!)FE#7/65_ 9TSO4_+AHMZ&S X%-BPM-U7F.\;;Z?>.
MIBO5,T3A2I[&54&+T%FL*W4O=GOIYBNTKDY:UM1TO<V;RL-K'VEC#IUTK-78
ME1$'G7%3TP&:&WAT3+2[LYK<">%WY-):KEPSY=38"I.=A6I8'X)%/%YVKH<9
MT3 .$\/[@UVV$CMG1ZP*DA16N4Y/XDKO-YLLZHB+JF!/_["8+!BNL%8Y90]
M [:HHSE*%I/6K^BM4RJZ0X$ZLI$FB=4T%S1_56ZX,)V<K'0$8C!6VQ]?*BYR
MZY;%<)^6@_68K ':H/SE4]LF@+MZ0W!E!5:?V1]H4UQ=*FTO^-NMJVD* $UH
M!QR.T@](.W6-2A4J:2>I0C>9@DDI%=!P)!'!&SGA ).320%L$W*BPRI,H)*=
MC35L2<;4/")VQ?=E8,,P%8NY-6S!&9):=#O(L@\-7JP4B.N=$I8/HIA;!:>X
MI*Q$*CBWVAV.'W":,7K!;Q?.N(45(^KH'>'RR 4B?1.;<D(+Y0ZJVE?RUAM
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MB$G8-KW?SJ3<,K[!(J<HNO5NC)JK17DH(;"U%]0B5",T.W+]UQM;*JW75\"
M@JW'3JUU;:RYIJLUDAS#BKN3FZM+M](;B;_V:Y6K!;&*KI,>TJDIM*L)X4(Y
M51N14-4,UGUX!/2.!^K*],@4]X1*,?,]YXJ+ZC[O]GGD$.TW&);YL!IB,(#.
MNM -VZP]U7TXV=8D<Y)J-0KDD.UZS:J(@TIC&V8U2IA* 3U4-BOL)]HJ959(
M$^73(D:UU&TEN%\HL5&;G^D;96U]L]MG&,AQ].4*MO81P1)8<F4G6*&!&!4B
M&H2FIX>1-4Y5;/*"7EO\5M6_,R16CJ./(#X\&'#2^IQXO%IVVKFM7-G%MG)W
M,)ABC<<@"!2ELO3*SKVS.L3&JKH(]<]-@D-M5GN*DVF<@T<8.3+1'&EC/6F,
M;2>XUL(A=(Z&\3M( ],-7^ "1[J0I?)D=S5S+)6GVTUU(T:@FG+RR4(OC91-
M]PK/\JF,:NUS]A(16B=C4O%:]"-Q9BH9S#R(8*9<R;"@/]WUX,U$5!%K'F <
M*V0SCYG$NA19XXBRQ(_&%,Q(N"R('K7I3W<R1.0QY7ULJ=EC]X,B?#Q&?FJ"
MK"H<58B#4\QY4B\H4&AWIU!:S^9T2VT"8W6?)=P5P53ODLH$2#<Z*SK'L,N
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MQ7[OM/_N:J=&<OB=VN?AS-_2!^ALA<@&/ _[5=QRV.Z+T\'Q+P.:S='YV=F
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MQV98G&QU!R1<(I$A@< [2-!3)63E;H+2#$=2+$/> 8<^4$A;W\17YC?+$HU
MN,/EHBCBABY5O_,+4/!3F_2 EVF>!KH #"/762MC0F#1+=Q[.@NM)FJAJP;#
MCPWCV!@#=):319H*_TM&-T@FL8?Z5\X?E!=9P(0(-1O%:<I<#M79G/\$=;O,
M,YCC$B@O&E5".[Y;J29#[*F->I)2W4G:;5(CU$[N!!? P9$KJ[66O'/6W&';
M%FF% R/#ETTNF>^"'D_3E]VN@*92BU'5;K?>?$M)K^ME\62".CV\#*L%MB7K
MS1>5)KK6[\OD:L<+LXXRU+6 :AQ5W+F:]WT4J?_:G+:B&76@O H0*AFICF#?
MYL48SO3&'%EC!$V4%N7*9Q73+1=PNGK/>0;ND(K=DB@D>PC/ TTB_W6^8PF$
MELS67J_;.5R Z$!V!\($'R3+?%[IP3/Z!.A<AP>UY9.^2G9Y##<!6'$T&L7S
M"JFZ3D.@(HS>9_D=V.13%OD1*LGL%NAVX%TF>JV>%/DMB#2RR>5+H&G .]'\
M)JS=!*W*^ BR=I8UTU"?2+?31JET4_40%L]@E6<*>Y^QXB-JDLB12,074UU9
MD?(OOHA)-.)/Y9.=3^KY_6K55SWZ_]G>#EXE<3I^#HQI&K^ (?ZUB(&B8";!
M]K9R!1Z?_*JFR8-O5_D<'GDZK]1TMH=Y5>6SY\%/^#-QU*J?':9 C\'>SH\P
MUS)/DS%,X<+](BW'WIV7/\"HG@D,@73?;[/R^AS(%&=M3^HGSYQPH@\=TMJ:
M'W!O>#N^9:H9UHP>TBS9WD%69>EOR 3G+&O6\MT8C>LOSW9^VM\#6]WK;+(8
MPA8)%&,*N/JN8P5L[ON(3NY(-&W76-H)3B;(7DF?((O2LCV8:[)3$A6;+!>%
M ?@PR)!I4E;B6"262V?$/R95(@S$[  !@XIZM4#[(">9'8_YLR <Z<-530C@
M:VCTI'&+<"&[64E($C!9TY".TC(GEZ!2+5&E[':\-C7)7]J"X9+\5:)T"9$U
M#!4A,*.C-K13'%A\XTC(XH4/HFZG5?UQ?)?P^2K!/<V'LF5HF">W">EE_[W5
MWS[L!5O_Z/T/_GRKWPMA(K"ESS\MM>WM[B/G7H?>MO>)R3>HW@0'[6!@/5CX
MD7-EOK^+-Z+&]^EG5@019,#*4%A+O!P74(\9[K$<Q2!7XW>[.\_JUY/#9G!$
MP=_K+WF')*M?:\O/V64!%/'KN_Z%TFLLMT20S, F3> *ILMN9XZ$-JX[%.XW
M[Q/10?U&#:BO(->K&^/W0<72F#J@M94+,;[$5N]VGFY%/<5%R!DPCI;L]567
MWED&W$ATRCQPF* QBOU-"N& %<97*I_'Z(?&Q<F]!GZU2*,"G1KTSDT.(ZB[
M77/A7"Y@YW[:W=T:D@E_2:_2%,[>7"&7FRW2*>F>2L@!,XOA;W"G2^W>[G;2
MZ*ZDF!'MMS7;D/U/PH_SN:U<*TX7)\@X@ZWEVB01>"F"+=/5)($'\F\>YS 9
MBS-)YN,(=9D ;'8V2N:P7#65-U'Q/J[8T$9K@9G889KGR &GP>G.!<;4C"37
MOW)#<J4V>D5(F2U1OB<A&6O+'DCO1C)26%,1X'A!=O$Z]-*@/B1>QR,@!J'R
M/]+;5M0/SC\;I0M\O]L1OXOSJ''PCM*<S;"/F5CO_HN$<P%B9#*QJ>Q!'*5A
M7ONY2W/75AW-[V$0'[^!.*-NQYJG0F40SL%@'#Z9X%U7S=OVZYH;J<M2]W!=
MJ=N,%WL\*Z48)!*5($;_ FEP0PQ? S'\XR'$T*JFDPISER_2,2KY20D<!UD@
MX5]B.RSH6"3H&AVAIY*<=B@)++!,XV'AE]H8NT,CS#5-T"8Q#X I=D.L#?VO
M.K#2[:@'=AZ90G^_G?#%YK&.1^SIB^"<%++R.4Y'9,N+X%>$6,&O/Y?#;/V]
M:2+E:A?6,QWRB=G;H#;@17"]G,,Z^T4T3$8O@K-H%O,FG>6X]*>.RTR]A;_Y
M\[OS_BBD_V!'L V;' +-38L<!!HB;//B.;HUJI@0(:(A@0U@^?V4:D0,*12$
MVI*TO5!9 R,$!E6$+U!8!XR=%66E-$@37ABET:)4S)442P3BHNJ6-"V.;B<I
MV>F3)B2,873TE[#?/ZK9'SR?(9@P\U831GF=R,  5@T$7#)H3GZ1Q<C[*\N:
MPJ7V"'IA6U]B\CCA0F>DUIFW6DE;0XI7-<P+P@#^_'Q_-XC:L8F@"#][OON4
MX(N![XD>F)U#VN7SZZ/_.L0)X5_^T332[=V\S=/%#,428EIP\B#.\6;1#HOP
M\VPQ"36R".[95UQM;3Z.5P0F/?*2AIHV[C'8VO5-IG.6]7B&0(-MPHLH-4TX
MGX\8-I.9LX)?H0O\(LG>@XR WP@)X JCH$QF"=@5L"7%-,H$ T!@G2FP2 S"
MCT:QF.<YX6\GBVQ4J7@<CX*_Y4GU>/MG>5F12Q%T!4/8CMN],?,RUW,.<3K!
MUKA'6@E&\$EYP#A[&4K<+"F0Q^!"&$9,.H??J4]^$ON>@PZ"S&8>$\?!8RLB
MT$%@=G$*DI/]*=,\!X8" X$F)+SAPD#Q:+A9]%M>(*6BHQA%6&Q8AX48I/.P
MH]9XCE9H7X*EJ*2YX 99:XQN&7PG_@!3EH [7U_MRYU'B69A*J#_J3'D7VV,
M83U18MP\Z%"PA AJI;237T28U#@R78W[A,DX2H"N5C+!5C&S-@_\L\@6IM!/
M)&'0P_U)=O?W2AARC7FV^G-+F&Y'1$SPI24,S,02,0%+&#[\SRMF,&/$E3/!
M%Q$S&H-FY$SP<#&S'G/="*.'":,3#Q"I8&\.DPTQDJ@)416!A% ^?*<5:^5S
M^"B7]#Z(HJV?%0X:X<.:R/HCX7\W>4I$-F<\<4L</":L($]:4%$5S$D 4'GK
MEXRO:8?/C/][;0,G:2VB3<.7HO<Q2>5Y7E*2B$:>\CCP11NENZ''AP"N]C>>
M)/$D[7_#GJ2OD;K'!"]Z$X- S9)12:;_(R8,K1T)><0M>N@<$LFNXYP:.V%(
ML?&W&#IP@5E-]/$(;1J?$#"09@.1JPCY1+D:)BF'9,VURM_H3V.#]A?H$CPT
M*F),PA6X $HP1-7Z8^Z2,3R.&9FL?SZ,4A)ZZFT2?B1;CF,2'SE(C>L"-DVO
ML;H!*3V]H>_)0_AY3.+!=)(($XB"(W@C'R>@]Y5+4+MG@04=.'[7/W*3DR>V
M%J5M(U"827@C4H'#,B3IY8.DG@G&HM\SX#<8\E[PVQQ5TTIO'06&LE$+A(U
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M+^V^];5#>#"$;:53=#TJD0+,JI^(_AK+9\&K<3TM=SA^0%?ST>.T9;5M897
M*GI/Z5D4"(?;N,BDN%?36;AB5QMMR>\3)_JCJV88(CW:Y4Q:EZ*AV;7-8*M:
M@^=8Z<;7X897EF<T!EZ>ST!F.G:'J571&G?Q>6%6>*#H8-4U:6-)UFW3%](4
M(V%>L&-J][BA'^UF7^4W;%XK4\-Z/#;U*U"MU>:;]MBPW>1A^EMESD8S6^Z9
MW3#=GF7QH&T#*N"P'JI>5'Q9"XC&)5U'[("U%1>%94#YUZ?R_B9<EKVLXHCV
M11D-CNDOPS:V%?Y6^QFYO7_+$W*@$MGBFI#;]L)5WVE8\.T?<JI8F<(U^FKP
M)G*4DAQ--OY +4FH7&"#,C&/&\&[0A75((5B327"';!=I5 A:/_AZJ4S.EHJ
M$9=U7+[F%Q]Q8I@?)SL=$G*:PK981'ZL2H6I81ALS;$PTKX]Z=X-)V?-OXF_
M%^BGT5-7JDAQ3V14*I5W4>FU/7)Z>EC$TU2&CQ8@X(KDW_&XC<T+(X7[T-X4
M07H8D;:L!FW798DME"Y//<D2U#],& SM#0TU_6-#/?^V@7H*U/-O&ZCG5P7U
MY-KO1\;/PRE0W4Z?;%7S8YLW:Z93ZX6BNRI%Y+P<"?K)_MG>#WN[N]4-!SF)
MW_@J+1+OI#ZB_IJ4^VNB2YS2J5(T@RH=6. D=LA%$I,@*]]V=:$N-EL7K+%6
M50;_/#:@^H-)CQNJ86$U:M'' O(1*NU\C2TVN,&&J4!$.^1B1AB9_>X&](9;
M$?HU4 G<(0V?<3L2^_3KVG5S'%FDC<SFE=5PT'5;#$'WG$5)BNUWN%9>LWQI
M'?)B*H18-384@(LQ5G1EW4UP;V93,:D-' 7# KLK4A-7VU.)EI@JDJT#8&:L
M#0T>2)<7ZXKV,59ASA$.W;JT6/9)"O2VY,::Y$\-MV^FQ;+K$PX+B0QM9 U$
M8]X+]@GGN6*(:=58U'XSPG2RK$"O&6,,$=-A\G(SQL\7\1B;P+: G<- 15)J
M=T(KTQ+*BG0Q>,**FM!N_8LJSQ>CZ%)'@[TJ0VP2.62/6EY8^.+VPD44<[=J
M:!3*0U!(002,-TA8 .Y\E&H/@EU7IF:H-7O*>D+O/D2YM_9H*#@")UFC4.CE
M.D#<2<?(.>=!9V50A7'D:Y02N QU!H;3;PVA^YQ'$=R31A'>CV17V.C&(5)N
M@^HOP9#UJH90[W;\$/6!CW1=<KK-TP684H7 ULT_X;+ /DJN:IK ^9@MO4M8
MS6%T-YWZ9!(E1=E$TU9.[K))6_8%,%2JJBI]JKE]S;/.G4"!("HE#<;C @U4
MRE/4UV8^!_W05%Y1//PRGF)=T;J;@OOPQOC1I[NHI<+-A=<)A.;8E%;<2Q)Q
M$9+M%C-B:UV2NZ5!+_4$UV(+';T8I/]@!X(R7PXQE^AWJI58WD>G*E/HL+C0
M8CA (DUF0$2"&J0U'$5^S)#U0B;6'5K%>/*)^B1_2WDA3,=J_Y1+9\X^_N5-
M:49:7_HV4F56-]/^+2:A$AQ"R;$R][NH7U**2 C6@&91*W6%_DCL0&;\;XVM
M2RK[*Y)NO]Y>>ITZ_@PEWX<H#]V#F)7^%QHX*Q>PECG03.KYR$U\X2E.;1I.
MFX"571%9N">7"&;/7I)):TC:9=5,KV+DF)7B'4W4.^B1!^YNHEJF^(.XD*Q>
M)M@S*M WU[2@I/EX^YC@!&6Z>H&JZJ_B/521.:D6E10:E/K );I5@9I!>E#S
MHVT)NR=4@%DD'COB5)BAAM;5<3HCP'Q\MDRP@F"4Q?FB1%0(IE?:^^QI6N"J
M]-W.$6-V@8U2LP-X@+I1_FW[/SUMWZ76G4NOHM8Y&].$>R#T+,Y&%CQ"!<L9
MGNK65:_Q7]D.:>D);&0:&^U;WHQU]R'T#[B-JC]@TQW<(=.82!RPFQK,=3_E
MSQL_I?@I?_XV_91?!R6;&LS/= UFU0J%U%9A19L:S%8-9K5!0.^IP'QV,'*G
M&R>-:GW&*")F%&2K:&,:W95:*]+-AFNMW_01(3A'1#F]PUS>Q*KHQ/33.WN*
MX^MZ:GV%XJDU8%8-@46U-!"'=3KQ%60Z%$H@TR=ZK)+JC9(V4W<(31,-!6W(
M4*E2TOJY&6^N9(G8,'E.]O-$5Y%UY#TUD\0&!=.,^SU->9EN@S*#9S)]H^MC
MNE:KC=%?I[FT[ETG.!J:!RDDP*2*+.;8*,/KW*[1<X*RNHVBK8K7VF2;,:)$
MF3GJ<4$LL!Y@=C1":R*9:"U.L.\"'?2I0[(@FJ=2.\%$@UNELV4*]=?2TZ,<
MC$S:W)@U5/E[2=$'<PM"U;&(-54I@2RFM/WOTJ-P&D05.52L<@\: <8Q5*T*
M\3-Y?26"V-):5DMZ$*K,9:[6,E:&3*,^LG;48B[E"!E FF(MX];\--'9&VEJ
MC:"UU&6R^PK.;Y8E["7AR/1Q.Y-"A=T^WT5&$6OKXQBA5JMRWT60S *!=!H-
MV5)=K75LI@6[(@B=-J+N$01NX7JM! #;3K6&$CHL*4G,7%VZE6XO&/FU:@5E
M08QX0:R/Z_2@9&(:F>B-<(&3JD]CJ)(X3#H9P?R0GB33V')%J*(>9@+B)E=L
M]":Z91B[38\<L=I(6JG;# /H_=,ML2TB4TUR$C8LR7:D^O@"[V.?H.95Q$*E
M<RCS&B5-I6@Y:ILEYA1YQ0PFQ+:($^7 (DZUU'W[HIG$15R&IJ^4=?2V$X>I
M #@UDV.]B1FP-I]@V0E6J"!&AXAZH=4S40L;I^L0N3QO+8:K:HZ;+59.HT\@
M/VJ8V]C[G+BW/"?MZUKKN"4PP&[&XY@PRE)9>FE7.RF-/VFL"CH&)R1)CK4-
M7=.<3/H\"I,*>;+R&5A/&LOZOD":SHHW3@96.#9\06K*Z@1QY;96O*%.BX5R
M:[M)H<0(V'^H* M=,I*25*NLQ%095=K!7(/]>R=CBI\T%23EN50RF'D0)T)1
M]?B<_G37@S<301:L>F#FEGR*QXS'NL1@@T19XD=#BES$7(A1C]ITGCLI^?*8
M<C5ZRJ3:#7<)C(YA'G&>"JHDQ,$IP#RJ%A05M+U42NO94+>4@S,&^&7,7><T
M6D@5@\-](UI1L/%6"ZHE=FAG #7JZKK!/(^>JZJ$)B0+$?YHT:&+=K"<D+:A
M:&$"%-PI1B&E#&/58G?!U=!LZ[DBX)#3^&"(H/+R_9+M:86.!-DSU?VY4;"G
ML=:^,*0WDXK16,IC.Y]LTP.%M>4D9MBSB\1<]SXK;;S9(N)R 5_:>_;,-:^X
M':_T/J!B-MKBIWOGI .;NG6F'[BQ+-5O8T]A9%\[75('+."RBV]5RL&/.W]M
M=QELKJ= ^"YC6X6DI#K#!XT@4GQ1?LV5[K1!D5/E;?D0ZX@&C4!Y\101,P6:
MZEJ'J:=EY=2H+U/6GZIB;FM4=0VC60.+BVD1%OHNTQDK.#]5F +H]C:!3>8R
M<=0[Q\@%=$S090/+5]-R;701)N@ TJ$I8%.W29XZN7XU=B"OU5F!TZ,>[G^H
M-"TG9R;"E$B+29'*AR'5>-S*@+ZUL(9Q!O^HG<%ODA*=&!P<VWB!+2_P6:Y[
M"0''O3* GN ME8Q62*T7P1GV#*HJ;JF*E'X4E3<>:W:<QPPUD,B@;?6)N28E
M^Q2\2.$%2BH2Q-9NH><4V3"CEG00%;%UU;VHQ0/]=&O< VD?6L:,$Q6D&@SN
M*_L[P3O;<2SN+XUB, W0[=(D=8Z1F:*#&* G-Y::M$HHLNY[MV-F#!9#[GR;
M(OSB__1W=I)E$M=S?W;;$Y==Z+2&9JW(WE[+5T?PC@RVDP8NB1*<Q,.:!-_<
ML+4BK'N[FQ"KA%CW=K_-&.M72]_LW3S-2T0I@K(X ;7]& V/Q4B%0-Y@I1.M
M#MEA6,<M,,J! 1FM43DVX@1F5:\0/=$)ZFVIL<2J3 N$%">(?\/YC=WYS9SY
MN<74"H-Q!>(O*H9'J?J()C'4Y?(Z(H26"[DQK/&E_;B:04A(4MC4629)A3HY
M?T4A@J32S6%KC16MV7@:Q+*7<YZ7E03>B,.#[28II;4@)OY(@C]N JZU08W-
MH5"$;"KZ?NV3(W4>.QMQYGJK4[6YX[B)R7M,-*;85S86KR9C[Z3RC)DI[4N:
MQ(NUIKP15.*.O(JJ18&8V!!A !G]#96:A/\65R.G-S-A=/$XYG/,>HW'5,5(
M>>(J'=XE:T=?.-;3YDFA:4JK428LB,888>$E2)UDKL<F<NJR2!,8SK[@@52=
M,D+6JNHO/$@C^B7QZ SVA4NL2/L9>X@-C8A3KZ^3?X%&B-\]1K;5>A/;>[0L
MEP=MC%>.,?8W]& ?;8G1: M7,9-$QT.A2AM2E,SD7+,[4>(_;LT2&XG!81F2
M/P(;QE@[8U?U)77;DC7L%8W5L'5\LKJ46TW,GV8:OBO>I5XB8K,=.9](),O7
M&DUE#VA4+<6]U4Y4(@E+B7$66( ^I^ CS*R8JM IA>,7# O&D>0PNITLQN1]
M3(989]%.-'S-1=-)5M3(+TT5SEH7!%+5_@2B.D0&I&8D1994Z7>?\TE%."4U
MM#2P9.&7VD-LNZ-JCJ<TNF,WUU22=KE*K^+)MELX=TO0O8F*]['H:2VM&62&
M*;JJQBNUO<@$-F5YJJ6JN\JU3T9[)%44S*X^E" :Q-,E?.5GQ#U:BYBJPF6Z
M"5S=/]D"P,"H+&*NS*T.&;^.0"T)FB.Q+U5E4/1:9IAM5%*U)-:?J/ CEU A
M0ON / VTGHS]L'P-RF!$Y1$;X4!3JEPM7X!&XCO98C<,'% F""[W#?+8F@#+
M2&?'<;FXO-! =!/)IA$^=3>PAS'K+R\N!N)STLA'U3D6;_%=1*59I?0-4S &
M=FW?O _L1GK1TE*UK*:(+9#'F=0G1!YJ:</<4C1S&RD@WBE?3%6^GMM=Q([!
MJ8RXEO01)^^LV=[8#H8AC:O<3I.XILOC8X44MI?B]\0OZ0>X,?D09:?JCP1"
MEP)=5MDC(7=NUMT(.V&Q*XX[$&/B2JA$_-,<I/<DHM!!60);,]9741!8!O>8
M(V 2_.)^X 8@:"G%ZAG5),8G!UBY5IT,R*J5@E0<-->^1Y4\5_-WN@QKBLDH
M6*,*F$I!H;"F2Q,_.XTS+%MCY=*@9V6:$RG5P'"P"O0PBI&)XHW=O?.H<+L'
MU).LL=\\!Y2X5KJ"AQ+[07[:#.DTJVN9C#,]."-R>6S5HLL1P:K V+W;3;U]
MBK&J>EV/@"I^395^TGC**%LBZ56L>TUMHR9HN/D6IE%2YDPQ8E"OI4[$$SSU
MDG:$B]):2Q8Q$TD6'D>,=&28&4VIJG$M55U040O0Z3#,QTN%]/L-[F@YYM"R
MDA:AV<_0;"A-)L[4N>KM0S+F:\D*G%7LR:-3?=O28BT7\M[&A:Q<R'O?L OY
M:Z/M0VFSS$*1%$KASJS]U[L$(VC:5/E0@+0V^.%Z79!,FJE;6L0+"5W-6$TP
MGOZE6:/-8P4!&7KE3SL#!O,#.3!"A/(QZD<K>/'&524 E_^P-L>J445%MA/I
MRP>*;Z;T'O(T:,>\RB<&<8E0*2F/S;H<\#"P#"M_V,  ;TT.NP_;V\0O;0!+
M*^L\-5"$%'/2NN_H?9;?I?%X&I=&8ZNKG2-Q,-^K=DG[]LH"VYB\?Y7-D:.G
M A_B<OX<DW>"^H)ADL8;%B1/(EQD^H!&GDL:!J,"R;J/L4)Y6L^RVU##P51P
M*QD9RP4[0P8?YM@T5^"E9Y@YL"CX6,=QE J@B^L,I!&Q4E.7P%"!B468Y$&A
M%,)Y&5M+),(<R\A3KABF4="$=-")/Z00+7=<;CC^#8SRD0V*,0T ! Y#A59+
M]LRAQ1.7+> 3MHXU$VEBIL7-ZTN<K%4Z13)ENP5W$Z\2#()5!&"32IV)L33(
MVT;Q+ZOG)8M=%MSL!2.CB8L@!.-H%DWCL@Z\;HI;S"1TJ\.PU"6+D2QFD[+@
MYB"B@U'5Y"D%EQ@+A=B.$33V\?[2KI*K)71\M)*24LH1P:6DNGRZ8Q6<B61'
M84$:C#X23Y<0$C^*\=1Z\@NAF5/5S(6\-K*H\<+*EY#\3-91#!&Q0-)$,.&D
MT7;J,;2\X1X'-U;-0%VZ4E?W"'47#@U$&TO18#LZ&3A]I74CP;RP"APUBMLU
M"=PNB*0+TZEZ1RI&HU!EY"FGLD<Z6[7>'*U>!6ESW <)0U2LOK1P7TX3.^<=
MI87A9DIKERVFC _C.XR RQ!L_E;7E7%O=FL1%'1Z"!NNYU*&XB:"BPV45IB4
MOD1CB$VQI'F1W"9I/#5U@!0#99J:4HI"PA6WN/. +-9]GOM,.6$/KH4O*VVT
MZEX-Q#0]XHA'FT$3+I-6>$(0Z,"#'XV ^A/LY%?[Y(9Z#WX3Q9?Y>$/I)2I5
M;8J9$Z%4\%;DL>HB*&3%<,E <R//,*.+2BVAVL1B.M2]=ZS/ZKIGH[J#'1UZ
M:\9'J1>+Z.I :C%7IA/E@&U_!?<88U,C:FPV0R$>F49I1.%Y63J2ED4X@W+1
MM0,$"3\U@#!/673;VRK%^M3\<M;K=/( 1V?C0K)9L&Y5QIYG"^E"(4'?'C$?
M9]F\I+)TT9VLUEKIAO;7\WP^W7@^E>?SZ3?L^?P:Z?L]8^Y4$XF2[=@^%6\0
M,]9*A&^ON^.I@6-I#%0TW JPF-Y.PN58:T@R5:$/WY4^$H$4Z &^--1%0<4:
MUKW(> BC#W/UB48U6#6M-=Y3"8+2'&X%KRZX\64VUGJXTFF<%:@2P\W<Y/8\
M>"H1*)X_VO5Z]8+ J$&N-K=AW0<I0P4188"6D]9;FB4O9OF82^*@*)_Q22JU
MU!R\0%($'*&]IZIJA7C7&QJI:GR4Q<$-IAKR#;-/L>[S4V^0(HOO; [S8,9\
MBGK9.)7"WN&QH)]E#OI70K602-5J;[NDK5[M0K=J<W "LQ26&-I5'_'4R!TO
M*J7AA=T.*;#HQDDF+37I&X/#(S?),!$-F"LC>[_.VC'7F=*?M:ID9&:*E5,R
M5#D U4@"HI%Q**B@(#GRLTBC+[BJYMAR(]H<L+">(9!R.WO<D.Y!1J3[.B;,
MHFT^W<B/=//:AEQ1@H2J<V>)\@%0GR_^1Z;Z:2D %J<<"SQV3H6"3??M2/N/
M'5_IG^N0?"KODX/_Y_G?(P_Y\D0O[>3@\<?:NJ)R?:A"D6[[BAHRE[W/,_KG
M7*DSRBK#;']CF"G#;/_;-,R^'+VNR!8Y.0O>G5R?#:ZN@G>O!Y>#\U=.X*G;
MP4J"U+"@5D=0=!*K2*:5>\#0BT6F:FG:V1IN4<!)4I25H!_1I$+$[2=4,K]4
MULPZXSZMN76N^X>G@^!H<'IZT3\^/CG[Y>]/=I_0OZ\N^D?JW^HV,!_ H%DT
M+^%"J+^]"-:?\ETRKF[PT=WOGAS@#"[5Y[$!!]8[4RN &^8N*8TGU1.Z,B^O
MC_7NP5_E%ET?!T?G./&SOS_9AT4>'O1'59PF.)OJ+B_>PRQ.LA&<].$!O0?_
MN?SD<ZC_T)G6TR?VKW_O^.JM.;J?LZEA0<B;G_AW:/4KA\OG;1.O4<$*:? (
M*Q2J^0F)9M6RY+EGWSTY<-;A_OI'^#5)",]1N4_N[WWW2=?CIQA[ @?7Z-_W
MS,PWC1_H_GYV]O$Y&!?=7[ZIJI?H2EWGV4;74;K.LXVN\T<PN8!^S\ZO3XX&
MP?FK8/"/P>71R=7 INC'NCB?Z7J^.C^[5I^F)S@'*2^ ,!;S>5Q@080G!]?Y
M\\"(XF[')XOQ4W^*;?&I>5M[/72B=SODVI(ZO.+XCQ%^5-JXA.!_Y7^-ND6U
MFDM6K:%:)E5LBLOK;N_D*4DF)N,>76>4)*-:F5.]B5(G2.J\2M7I1<6P&:"@
M2WK7JAACSI;QW;GEYU4SU6]#U>:S?]H#SKSDII=2V0DSH22ABUK4;L%)8>*X
MV;9A_J'W_$OUC/SR72MQ!L'W__?GOSX#H8ZH[32Z V(C?((&T+S-R'E\A5C=
M\D60%YO]XOV:=#L6,(XR(SWE8]H[KY;4I$[E0X2U_&D=]T'J7:21F^N([2YB
MR:G':FEA.Q2+/J12F86'S:(/R6PQ:Y^<,,E:06LI_5N'?9-??A2/T2/8,DLJ
MZ?8ML:-]8$?8@C%6+2VH0GTS8YZ2>JPJT[;H8B0L41''Z.A!IAO37F,8I_G=
MIV-B?R"9SBKD_Z[^WY>8TN?1^S[/*-?-O)$F7%==_4DNY8Z[G>-W_:.@+Y5F
MSXB/;(CPST:$F\WX8V_&%Q1PSQCU,F(\,YHY)]EM7%:Y54W;%F8)M0&2<K"1
M?@TA ?26*@@+XFT<3R2/$+']4JPG.*9&38MT&JTJ_TR(][V?]_>Y6#N#;/ZD
MBL?ZKH'_OCKYY:Q__?9RT.V<OPI>GY\>#R[_Y[.X [Z 7TAOSYDH5DR9B#D9
M(*I[^3RXY]:N_;]'/^"3 Q-MAY68@G0!_SQG^+I>8;?#2\2 XT<L\W.=B&\=
MG^14'EU=HAK?C[F"1U\"MD3Z=#?@<\_^,S'6=5 ?/WZN^,<ZWOX_?8"A?O02
MJOIL$OV12(Z0ZQ3#&/SC]<GAR75P^-6'+G1@QE9/\,O;=S$N]WF088)0^N2@
M?X6:R9L!//;J_/+-XVHDZT]+[<[GUX_V=AD?@#B[:]6\U"U+9J6>JZY]Y/#C
M;K>(T03-+UV:#%ZK^]%.<)Q36M>BM-]RG8>Q+XU3ZJKN/";,;_66? E31X8&
MV@Q^[9^^'027@Z/!R:^#X[#E3.I=F4T&2J42[8I8Y]SI)J[Y'V%'#4;)QB35
M,4LN;@/A10]!);5"FQ1R8Q7>XTDK#N7'784T\<-5[I.V&B[U(R['NX/$*$I0
M^'BA/K3*1\S_P4-]Y!>VV!N-Y9ZRJO>53/HS[G"?ZQ!\-/E\A@4=!%Y,DWNR
MP<=^_#Z$W4=\\N(&DY&T;_AC-O;W;MDCK&HPBY(T^'WT\L=;UL-N"YJ0XX8-
M"?\. V4%?A6W_JMB4;7Z2=HO)!#&^\SRKV*-7_.!*):PSG%\^O/X) C5E2!)
MOS'UJ;3RKWIHRQ."762WE3>DS2W4.I8#VK??MHG <A_1UU:(%_36R']M;XTS
MR<^^>7K;?C@\/_XGP:M?7[\Y/?C_4$L#!!0    ( '"!J%;X+%?U7PL  "\I
M   :    96$Q-S@Q,S)E>#DY+3%?86-T96QI<RYH=&W=6FUO&S<2_BY _X&7
M7@,;MU*<%R?URP5U$J<)$*>^R.FA'ZE=2F+-)162:UGWZ^^9X:Y6DF6W!13?
M-0%BRUR2\S[SS*R.WUV<?7C9[1R_.SUY@]^"_AU?O+_X</KR^%'ZC:>/ZL?'
MKWY^\ZL87/SZX?2?#T;.QD/Q>&\:Q84N51 ?U4Q\<J6T65K(Q$!Y/7J @SAZ
M_F?/'8E2^K&VAP);CT14U[$GC1YCP>OQ)#YX>?SJY>GU1 ]U% <'_<?'CUZ!
MZ?-MD+M),E<V*L\T']IAF!YMF5KZ?RO-DSPJH^FZ.'/^,H@3:UUE<U#X^]/^
MOCC3QFAGNYUSKZ]D5.+<R%R5N$!@)5>%.(F]BXGJG4E_J:+X; OEQ4<9"OE%
M?*J,"O<KS]9UN$KIMRI$/9H_>/GVT^G9SQ\O,O$:3T;]3)S)N7B6B2=[3YZ*
MAV4AP^2HVUG7;B;>V[PO=CZ>#-Z<_.OP9/!QL"MV'IKB2^6.ZLT//?\EG!=Q
MHD3]\+4KI]+.ZX>[0A*/I'"C)&E<6Y'/A\KW)M(7RJHB$UY.=2$*-35N3@;K
M=FQB0]NQ",Y4$88-8@1",UTH(;V2XKV[$'(Z-3J7_#@3T1403=9N48 I&04B
M8R*#8+UC3=OH0&FDK8[Z"E>-O6(G2=>3'-/*YSB"9[;H=H(T2KB1.'CV+'O^
M8D\$L V#8$7C3.[*TED1HLLOQ0XN6%E07RJXHJ';=^DV,9/>2Z(%)A9DJBG]
M^?OW=SL01[;GIN35M!'N_V)O7TRA7#Y-:W^4L<27#,'E&D&S8)',)(D$A])T
M$4I,M"!6>M!5KS9MM1Q+GF*I+Q!JK;P32;JV0ETKG^LUYO=_:'G/8&%CQ% U
M6^40^M=EJ0KBS\RA+HBA0Z@DC Q&P+ZZGFJ(/6*#XF]G%;S+C,1<24^&-<;-
MR)?(O,W1_E<.]44 -H%^/]3>]5_WQ;^EMC,N$>*A+*='XK7K0W A\P@U0&D(
MB.O<5($TUAI7CNEG$P=N- )Y._Y&%47^.?8N!/BBRY4J."I)\#J#49KI=N!;
M*J? P$-X)3*.=]>Z3+[(A:=,A2=Y?*,TTO;RT=PX>#T\%\J50U=%3L,_I#2<
MB5 -?\->VAF0SL*(+$6[$<E@&++Z>;=#E]#=N;.%YJ27B#8,([DIF^2H0(UD
M02)MY1MY5ZZ8-J74.M'FR,)1&HX@.(+R^)P[/W6>4T"%3P&!_>UZ0U!YY:%7
MW%FHD'L]A.U@+,3(3)$OL-JXB&S,C2D+#E0RW;,=N;OS9)=,2"H?M)>C?-+J
MXX.GL#Q"4>)T@6MWEJKHZO:VF%))^J3&E>&B)]Z0<<O*C#EWX[Q7B0MLQ-W&
MP:XS'2?,0EM:5HH!'S#S)C\V.3M+2=NZ"+]75G@UUB$543[1[6P2RS<UF=)V
MB*2@);4:.8/+GN1PJP+TS#Q+C+4[2D1%(BD:;>-.8 #2>G().O$9Y1N/!D0@
MI&4Y# P=$I\^Z6<A^Q*?Y-^GUZBA=LRA4Z(BT-Z=P>GK79; +@N!.E1.^3(.
MGU#E$[%"PU,U]0E$]&M8*8%#%]"BY4+;*P6E^Y"UHC1X*0E!9SAAC+3ABLE
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M[ :>C\3]D]\L_/H<!1MDO_=U$Y'!<B(B[AR(##8.1' O2G<JKD2N,NK&DAB
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M6>%G6O1KKO\"4$L! A0#%     @ <(&H5F>#G!TI P  J L  !$
M     ( !     &%S;G,M,C R,S U,#0N>'-D4$L! A0#%     @ <(&H5BT:
M84O^"@  @(8  !4              ( !6 ,  &%S;G,M,C R,S U,#1?;&%B
M+GAM;%!+ 0(4 Q0    ( '"!J%;5,M^45 <  --7   5              "
M 8D.  !A<VYS+3(P,C,P-3 T7W!R92YX;6Q02P$"% ,4    " !P@:A6&GCE
M$J,;  ">E   %P              @ $0%@  96$Q-S@Q,S(M.&M?86-T96QI
M<RYH=&U02P$"% ,4    " !P@:A6_91'WZZC  "@30, &@
M@ 'H,0  96$Q-S@Q,S)E>#$P+3%?86-T96QI<RYH=&U02P$"% ,4    " !P
M@:A6U)_2"=16   J% ( &@              @ '.U0  96$Q-S@Q,S)E>#$P
M+3)?86-T96QI<RYH=&U02P$"% ,4    " !P@:A6G5!^.4Y%  "D;0$ &0
M            @ ':+ $ 96$Q-S@Q,S)E>#0M,5]A8W1E;&ES+FAT;5!+ 0(4
M Q0    ( '"!J%9Y=U;"<$(  !]E 0 9              "  5]R 0!E83$W
M.#$S,F5X-"TR7V%C=&5L:7,N:'1M4$L! A0#%     @ <(&H5M%2-%SY10
M*FX! !D              ( !!K4! &5A,3<X,3,R97@T+3-?86-T96QI<RYH
M=&U02P$"% ,4    " !P@:A6^"Q7]5\+   O*0  &@              @ $V
M^P$ 96$Q-S@Q,S)E>#DY+3%?86-T96QI<RYH=&U02P$"% ,4    " !P@:A6
M2RP;QO\*  #4)0  &@              @ '-!@( 96$Q-S@Q,S)E>#DY+3)?
A86-T96QI<RYH=&U02P4&      L "P#_ @  !!("

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
